{
  "meta": {
    "title": "00239_Late_Night_Pyqs_Inicet_-_4",
    "url": "https://brainandscalpel.vercel.app/00239-late-night-pyqs-inicet-4-1d27fa91.html",
    "scrapedAt": "2025-11-29T18:10:30.427Z"
  },
  "questions": [
    {
      "id": 54785,
      "choices": [
        {
          "id": 218605,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichomoniasis</span></span></p>"
        },
        {
          "id": 218606,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neisseria</span></span></p>"
        },
        {
          "id": 218607,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydia</span></span></p>"
        },
        {
          "id": 218608,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacterial vaginosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A woman presents with dysuria and yellowish discharge. Gram staining shows gram-negative diplococci. What is the diagnosis? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q9049722",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794124,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Neisseria</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of gram-negative diplococci on a gram stain is a classic finding in infections caused by <strong>Neisseria gonorrhoeae</strong>, which is a sexually transmitted bacterium responsible for gonorrhea. Neisseria gonorrhoeae typically presents with symptoms such as dysuria (painful urination) and a yellowish or purulent discharge, which aligns with the clinical presentation described in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gram staining is a key diagnostic tool that helps differentiate bacterial species based on the characteristics of their cell walls. Neisseria gonorrhoeae is a gram-negative diplococcus, meaning it appears as paired spherical bacteria that do not retain the crystal violet stain used in gram staining but do take up the counterstain, appearing pink or red under a microscope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Trichomoniasis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a sexually transmitted infection caused by the protozoan <strong>Trichomonas vaginalis</strong>, which is a flagellated organism. While trichomoniasis can cause dysuria and yellowish discharge, it would not present with gram-negative diplococci on a gram stain. If the organism had flagella, Trichomoniasis would be a consideration, but the gram stain findings rule it out.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Chlamydia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Chlamydia trachomatis is another sexually transmitted bacterium that can cause symptoms similar to those of gonorrhea. However, it does not appear as gram-negative diplococci on gram stain. Instead, it is typically detected by nucleic acid amplification tests (NAAT).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bacterial vaginosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition is characterized by an imbalance in the vaginal flora and typically diagnosed using Amsel&#39;s criteria or by identifying clue cells on microscopy. It is not associated with gram-negative diplococci.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The identification of gram-negative diplococci in a patient with dysuria and yellowish discharge is highly indicative of Neisseria gonorrhoeae infection, a common cause of gonorrhea</span></span></span></p>",
      "correct_choice_id": 218606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13066,
      "choices": [
        {
          "id": 52226,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers</span></p>"
        },
        {
          "id": 52227,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol</span></p>"
        },
        {
          "id": 52228,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic anhydrase inhibitors</span></p>"
        },
        {
          "id": 52229,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandin analogs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female presents with redness and pain in the eye. Examination revealed an IOP of 38 mm of Hg, aqueous flare, and corneal precipitates. Which of the following drugs must be avoided in her? (INICET MAY 2021)</span></p>",
      "unique_key": "Q9648016",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Prostaglandin analogs</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The clinical vignette suggests anterior uveitis with a raised intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues like latanoprost increase uveoscleral outflow and lower intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues act by stimulating prostanoid receptors on the ciliary muscles, leading to the release of matrix metalloproteinases that increase uveoscleral outflow.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues should be used with caution in patients with uveitis, iritis, cystoid macular edema, and herpes simplex keratitis.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues are the least suited for use in this patient as they can worsen the anterior uveitis.</span></li><li><span style=\"font-size:12.0pt;\">PG Analogues can also cause cystoids macular edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Beta blockers:</strong> These are generally safe in uveitis unless contraindicated for systemic reasons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mannitol:</strong> This osmotic diuretic can be used for quick reduction of IOP in acute settings but does not exacerbate uveitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbonic anhydrase inhibitors:</strong> Also safe for use in reducing IOP in uveitis, unless systemic contraindications exist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with anterior uveitis and high IOP, prostaglandin analogs should be avoided due to their potential to worsen intraocular inflammation and the risk of inducing or exacerbating cystoid macular edema. Other options such as beta blockers, mannitol, and carbonic anhydrase inhibitors can be considered based on the individual patient's overall health and specific eye condition.</span></p>",
      "correct_choice_id": 52229,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6703,
      "choices": [
        {
          "id": 26781,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical antipsychotics is the first line treatment</span></p>"
        },
        {
          "id": 26782,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevalence is 7 -10 percent in general population</span></p>"
        },
        {
          "id": 26783,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression is a common comorbidity</span></p>"
        },
        {
          "id": 26784,
          "text": "<p><span style=\"font-size:12.0pt;\">Contamination is an uncommon obsession</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is a true statement about obsessive compulsive disorder (OCD)? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q8432259",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794200,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Depression is a common comorbidity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Obsessive-compulsive disorder (OCD) is a condition characterized by intrusive, repetitive thoughts (obsessions) and the urge to perform repetitive behaviors or rituals (compulsions).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Many individuals with OCD also suffer from depression. The two conditions can coexist and may even be related in some manner.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Atypical antipsychotics is the first line treatment: </strong>This is false. The first-line treatments for OCD are selective serotonin reuptake inhibitors (SSRIs), clomipramine and cognitive-behavioral therapy. Atypical antipsychotics may be added as an adjunctive treatment in patients who do not respond to standard treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Prevalence is 7-10 percent in general population: </strong>This is incorrect. The prevalence of OCD in the general population is around 2-3%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Contamination is an uncommon obsession:</strong> False. Contamination obsessions are the most common types of obsessions in OCD. Individuals may fear germs or becoming ill and may wash their hands excessively as a result.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">OCD is characterized by obsessions and compulsions. Life time prevalence is around <strong>2-3%</strong> and is more common among females. <strong>Most common presentation is obsessive contamination with compulsive washing</strong> followed by pathological doubt with repeated checking. <strong>Most common comorbidity is depression. First line treatment includes SSRIs and chlomipramine.</strong> Atypical antipsychotics are used as adjunctive treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: A Short Textbook of Psychiatry, 7th edition, Page No 95-97.</strong></span></p>",
      "correct_choice_id": 26783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11864,
      "choices": [
        {
          "id": 47422,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antihistone antibodies</span></span></p>"
        },
        {
          "id": 47423,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-dsDNA antibodies</span></span></p>"
        },
        {
          "id": 47424,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticentromere antibodies</span></span></p>"
        },
        {
          "id": 47425,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antinuclear antibodies</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young patient presents to the clinic with erythematous lesions over the exposed areas of the skin like hands, arms, chest, etc. She also complains of arthralgia and breathlessness. Which among the following antibodies will be useful in diagnosing this condition? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103830-am.jpeg\" style=\"height:257px; width:300px\" /></p>",
      "unique_key": "Q8595702",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794127,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Anti-dsDNA antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient exhibits symptoms including erythematous lesions on sun-exposed areas of the skin, arthralgia, and breathlessness, which are characteristic of Systemic Lupus Erythematosus (SLE). The rash described is typical of an SLE rash and not dermatomyositis, which presents with rashes over the knuckles known as Gottron&#39;s papules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For diagnosing SLE, anti-dsDNA antibodies are very useful due to their high specificity. Although their sensitivity is relatively low (30-50%), the specificity is very high (&gt;90-95%), making them reliable markers for confirming the diagnosis of SLE. Anti-dsDNA antibodies are also associated with disease activity in SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antihistone antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are primarily associated with drug-induced lupus erythematosus, not classic SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anticentromere antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are typically seen in limited forms of scleroderma, particularly CREST syndrome, and are not associated with SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antinuclear antibodies (ANA):</span></strong><span style=\"font-size:12.0pt\"> While ANA is a good initial screening test for SLE due to its high sensitivity, it lacks specificity. ANA can be positive in a variety of autoimmune conditions, thus it is not as specific as anti-dsDNA antibodies for diagnosing SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-dsDNA antibodies are highly specific for diagnosing Systemic Lupus Erythematosus (SLE), despite their moderate sensitivity.</span></span></span></p>",
      "correct_choice_id": 47423,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54849,
      "choices": [
        {
          "id": 218857,
          "text": "<p><span style=\"font-size:14.0pt;\">PEG tube</span></p>"
        },
        {
          "id": 218858,
          "text": "<p><span style=\"font-size:14.0pt;\">NJ tube</span></p>"
        },
        {
          "id": 218859,
          "text": "<p><span style=\"font-size:14.0pt;\">NG tube</span></p>"
        },
        {
          "id": 218860,
          "text": "<p><span style=\"font-size:14.0pt;\">Chest drain tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Identify the device in the image: (INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/29/screenshot-2024-08-29-163000.jpeg\" alt=\"\" width=\"400\" height=\"322\"></span></p>",
      "unique_key": "Q1528938",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794117,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) PEG tube</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The image provided shows a tray containing various instruments, including an introducer, a tube with a bolster, and a guide wire, which are characteristic of a PEG (Percutaneous Endoscopic Gastrostomy) tube kit. A PEG tube is used for providing nutrition directly into the stomach in patients who cannot swallow food. The distinguishing features of a PEG tube include a retention bolster that secures the tube to the abdominal wall and an inflatable balloon at the end that helps retain the tube within the stomach. The presence of these components in the tray confirms that the &nbsp;is a PEG tube. This procedure involves making a small incision in the abdomen, inserting the tube, and securing it, which is why the tray includes various tools for this process.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. NJ tube (Nasojejunal tube)</strong>: An NJ tube is inserted through the nose and extends into the jejunum. It is typically used for feeding but does not require the surgical kit or bolster shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-181627.jpg\" alt=\"\" width=\"300\" height=\"315\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. NG tube (Nasogastric tube)</strong>: An NG tube is a simple tube inserted through the nose into the stomach or intestine. Unlike the PEG tube, it does not involve a retention bolster or a complex insertion procedure, making it less likely to require the tools seen in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-181713.jpg\" alt=\"\" width=\"400\" height=\"354\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Chest drain tube</strong>: A chest drain tube is used to remove air, fluid, or pus from the pleural space in the chest. It typically does not include the bolster and balloon characteristic of a PEG tube, and the tools in the image do not match those used for chest drainage procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-181748.jpg\" alt=\"\" width=\"400\" height=\"166\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The PEG tube is a specialized device used for long-term feeding directly into the stomach, identified by its retention bolster and the presence of specific tools in the insertion kit. Understanding the key components of the PEG tube kit helps differentiate it from other types of medical tubes</span></p>",
      "correct_choice_id": 218857,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23169,
      "choices": [
        {
          "id": 92639,
          "text": "<p>A</p>"
        },
        {
          "id": 92640,
          "text": "<p>B</p>"
        },
        {
          "id": 92641,
          "text": "<p>C</p>"
        },
        {
          "id": 92642,
          "text": "<p>D</p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young man, aged 25, arrived with complaints of being unable to bend the distal interphalangeal joint of his 4th and 5th fingers. Additionally, he faced difficulty in gripping a piece of paper between his fingers. Where is the probable location of the injury? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/14/whatsapp-image-2023-06-12-at-190121011010201024.jpg\" alt=\"\" width=\"200\" height=\"413\"></span></p>",
      "unique_key": "Q7369971",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794196,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. C</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given clinical scenario depicts paralysis of medial 2 lumbricals and palmar interossei which are supplied by ulnar nerve.</span></li><li><span style=\"font-size:12.0pt;\">Ulnar nerve lies behind medial epicondyle, marked as C in the given image.</span></li><li><span style=\"font-size:12.0pt;\">Ulnar nerve supplies Flexor carpi ulnaris &amp; medial half of flexor digitorum profundus in forearm and in hand, it gives motor supply to hypothenar muscles, adductor pollicis, all interossei and medial two lumbricals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ULNAR NERVE PALSY</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>High ulnar nerve palsy (Injury proximal to elbow)</strong>: Paralysis of all muscles supplied ulnar nerve in forearm and hand. Sensory deficit in the skin of hand.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low ulnar nerve palsy (Injury distal one third of forearm)</strong>: Sparing of forearm muscles, Paralysis of hand muscles. Sensory deficit in the skin of hand.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. The structure marked as A is the deltoid tuberosity. Injury to this part is rare. Its superficial location places it at a risk of trauma, fracture, and sequestration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. The structure marked as B is the lateral epicondyle. The lateral epicondyle is usually involved in the lateral epicondylitis or tennis elbow i.e., the overuse injury secondary to the eccentric overload of the common extensor tendon at the origin of extensor carpi radialis brevis (ECRB) tendon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. The structure marked as D is the anatomical neck of humerus. Here, the shoulder joint capsule is attached. Injury to this part is highly uncommon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The marked structure C is the medial epicondyle. The Ulnar nerve passes from behind the epicondyle. Injury to the ulnar nerve at this area causes ulnar claw hand i.e., the extension of IP joints of 4<sup>th</sup> and 5<sup>th</sup> fingers; along with weakness in grip of the hand.</span></p>",
      "correct_choice_id": 92641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10230,
      "choices": [
        {
          "id": 40886,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 12 months</span></p>"
        },
        {
          "id": 40887,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 12 months</span></p>"
        },
        {
          "id": 40888,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 6 months</span></p>"
        },
        {
          "id": 40889,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 35-year-old patient presents to the outpatient department with a satellite skin lesion. On examination, the patient has one hypopigmented lesion and one thickened nerve. The images of two blister packs are provided. Based on the WHO / NLEP Guidelines, which treatment is most appropriate for this patient?</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture2_e7rPz6c.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q8554025",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794189,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<h3><span style=\"color:#1F3763;font-size:10.5pt;\">Answer:</span></h3><p><span style=\"font-size:10.5pt;\">The correct answer is <strong>B. Packet 2 for 12 months</strong>.</span></p><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p>&nbsp;</p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:494.25pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>World health organization (WHO)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\">No&nbsp;</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\">≥1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><span style=\"font-size:10.5pt;\"><i>*If a case has any one of the three features suggestive of MB, he/she is classified as MB.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:13.5pt;\"><strong>Treatment Regimen: WHO &amp; NLEP (Post April 1st 2025)</strong></span></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TAhJtvE.png\" alt=\"A chart of medication\r\n\r\n\r\n\r\n\r\n\r\nDescription automatically generated with medium confidence\" width=\"337\" height=\"172\"></span></p><figure class=\"image\"><img style=\"aspect-ratio:184/239;\" src=\"https://tnhealth.tn.gov.in/tngovin/dph/images/mbadultdose.png\" alt=\"Health &amp; Family Welfare Department, Government of Tamil Nadu\" width=\"184\" height=\"239\"></figure><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QuOAkXI.png\" width=\"463\" height=\"250\"></span></p><p>&nbsp;</p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Other Options:</span></h3><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option A: Packet 1 for 12 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option C: Packet 1 for 6 months:&nbsp;</strong></span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option D Packet 2 for 6 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">Although Packet 2 contains the correct medications, the treatment duration of 6 months is insufficient for multibacillary leprosy according to WHO guidelines, which recommends 12 months.</span></p><p>&nbsp;</p><p><strong>OLD NLEP GUIDELINES to diagnose Leprosy&nbsp;</strong></p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:469.5pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>National Leprosy Eradication Programme (NLEP)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\">No or 1 nerve</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\">&gt;1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><strong>OLD NLEP GUIDELINES to treat Leprosy&nbsp;</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cv8eRBC.png\" alt=\"A chart of drugs and drugs\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"243\"></p><p><strong>OLD PB MDT with 2 drugs followed by NLEP:</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F3OLXAd.png\" alt=\"A green label with black circles and white text\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"257\"></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><i><strong>Educational objective:</strong></i></span></p><ul><li>As of <strong>April 1, 2025</strong>, <strong>NLEP follows WHO guidelines</strong> for both <strong>diagnosis and treatment</strong>.</li><li>Classification is based on <strong>skin lesions</strong>, <strong>nerve involvement</strong>, and <strong>skin smear</strong>.</li><li><span style=\"font-size:10.5pt;\">For a patient with <i><strong>multibacillary leprosy</strong></i>, characterized by <i><strong>one or more thickened nerves</strong></i> and <i><strong>multiple skin lesions</strong></i>, the appropriate treatment is with a regimen containing <i><strong>rifampicin, clofazimine, and dapsone (Packet 2)</strong></i> for a duration of <i><strong>12 months.</strong></i></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Jopling’s handbook of leprosy, 6<sup>th</sup> edition, page no 10</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Andrew’s diseases of the skin: clinical dermatology 13<sup>th</sup> edition page no 338, 339, 345</strong></span></p>",
      "correct_choice_id": 40887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24753,
      "choices": [
        {
          "id": 98973,
          "text": "<p><span style=\"font-size:18px;\">Plot histogram</span></p>"
        },
        {
          "id": 98974,
          "text": "<p><span style=\"font-size:18px;\">Mantel-Haenszel test</span></p>"
        },
        {
          "id": 98975,
          "text": "<p><span style=\"font-size:18px;\">Box whisker</span></p>"
        },
        {
          "id": 98976,
          "text": "<p><span style=\"font-size:18px;\">Shapiro Wilk test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>All of the options listed can be utilized for assessing data normalcy except?</strong><i><strong> [INICET MAY 2023]</strong></i></span></p>",
      "unique_key": "Q8699091",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794199,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Mantel-Haenszel test</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Mantel Haenszel test is used for&nbsp;sample sets that are able to be placed in two by two tables, but unlike the Fisher Exact test and the chi-squared test, there is no “n” requirement.</span></li><li><span style=\"font-size:18px;\">Normality of a data refers to&nbsp;a specific statistical distribution called a normal distribution, or sometimes the Gaussian distribution or bell-shaped curve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Plot histogram:</strong> Correct for assessing data normalcy. A histogram can visually show whether data follow a normal distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Box whisker:</strong> Correct for assessing data normalcy. A box-and-whisker plot (box plot) can reveal the symmetry and spread of data, indicating normality.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Shapiro Wilk test:</strong> Correct for assessing data normalcy. The Shapiro-Wilk test is a statistical test specifically designed to test the normality of data.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Mantel-Haenszel test is not used for assessing the normality of data. Normality can be assessed using tools like plot histograms, box-and-whisker plots, Shapiro-Wilk test, Kolmogorov–Smirnov test, etc.</span></li></ul>",
      "correct_choice_id": 98974,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54301,
      "choices": [
        {
          "id": 216673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acyclovir</span></span></span></p>"
        },
        {
          "id": 216674,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids</span></span></span></p>"
        },
        {
          "id": 216675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics</span></span></span></p>"
        },
        {
          "id": 216676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 40-year-old patient presented with left facial weakness. Routine lab workup was normal. What is the next best step in management?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q6451864",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794118,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Corticosteroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presentation of left facial weakness with normal routine lab workup suggests Bell&#39;s palsy, an idiopathic condition characterized by sudden onset of unilateral lower motor neuron facial paralysis. Bell&#39;s palsy is a diagnosis of exclusion and is the most common cause of unilateral facial paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The first-line treatment for Bell&#39;s palsy is corticosteroids. They are most effective when started within 72 hours of symptom onset. Early treatment with corticosteroids can significantly improve the chances of complete recovery. A typical regimen is prednisolone or prednisone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Prednisone 60-80 mg per day for 5-7 days, followed by a taper over the next 5-7 days.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note &ndash; In t</span><span style=\"font-size:12.0pt\">he severity grading system, <strong>House-Brackmann grading</strong>, if the patient has <strong>Grade 4 or Grade 5</strong> severity, consider adding <strong>antivirals</strong> such as <strong>acyclovir</strong> or <strong>valacyclovir</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acyclovir:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although acyclovir or other antiviral agents like valacyclovir are sometimes used, their benefit is less clear. They may be considered in severe cases of Bell&#39;s palsy, particularly when there is a suspicion of herpes simplex virus involvement, but they are not the primary treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Valacyclovir 1 gram TID for 7 days or acyclovir 400 mg five times a day for 7-10 days.</span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note - </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valacyclovir</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> has superior bioavailability, superior efficacy, and lower side effects compared to <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">acyclovir</span></strong><strong>.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> There is no role for antibiotics in the treatment of Bell&#39;s palsy as it is not caused by a bacterial infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While physiotherapy, including facial exercises and eye protection measures, can be supportive, it is not the primary treatment and should be considered an adjunct to corticosteroid therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best initial management for a patient with Bell&#39;s palsy is corticosteroid therapy. Early administration within 72 hours of symptom onset greatly enhances the likelihood of complete recovery. Antivirals may be added in severe cases, but they are not the mainstay of treatment.</span></span></p>",
      "correct_choice_id": 216674,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4066,
      "choices": [
        {
          "id": 16243,
          "text": "<p><span style=\"font-size:12.0pt;\">Presynaptic inhibition of GABA and glycine release</span></p>"
        },
        {
          "id": 16244,
          "text": "<p><span style=\"font-size:12.0pt;\">Presynaptic inhibition of Ach receptors</span></p>"
        },
        {
          "id": 16245,
          "text": "<p><span style=\"font-size:12.0pt;\">Postsynaptic inhibition of GABA</span></p>"
        },
        {
          "id": 16246,
          "text": "<p><span style=\"font-size:12.0pt;\">Cleavage of SNARE proteins, preventing Ach release</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man developed generalized muscle spasm with arching of his back as shown in the image, a few days after sustaining a puncture wound to his leg. The toxin responsible for this type of abnormal posturing acts by which of the following mechanisms? (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-48.jpg\" alt=\"\" width=\"300\" height=\"112\"></span></p>",
      "unique_key": "Q8640707",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794188,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Presynaptic inhibition of GABA and glycine release</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This abnormal posturing is caused by tetanospasmin which is produced by <strong>clostridium tetani</strong>. It <strong>inhibits presynaptic GABA and glycine release.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-49.jpg\" alt=\"\" width=\"400\" height=\"205\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clostridium tetani is an <strong>obligate anaerobic, gram-positive bacillus with terminal round spore (drumstick appearance).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tetanus is manifested by skeletal muscle spasms and autonomic nervous system disturbance. <strong>Tetanus only affects skeletal muscle, smooth muscle, and cardiac muscle function normally.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C. tetani produces two exotoxins–tetanolysin and tetanospasmin.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Tetanolysin is a heat-labile, oxygen-labile hemolysin antigenically related to the oxygen-labile hemolysins produced by C. perfringens, S. pyogenes, and S. pneumoniae. Tetanolysin damages otherwise viable tissue surrounding the infection and optimizes the conditions for bacterial multiplication.</span></li><li><span style=\"font-size:12.0pt;\">Tetanospasmin (or tetanus toxin) is a heat-labile, oxygen-stable, plasmid-coded neurotoxin responsible for disease manifestations. Tetanus neurotoxin is released upon cell lysis after bacterial growth under anaerobic conditions (e.g., in deep puncture wounds). It is antigenic and is specifically neutralized by its antitoxin. Its toxoid form is used for vaccine preparation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Tetanus Toxin-</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tetanus toxin binds to polysialogangliosides receptors present on motor nerve terminals which results in toxin internalization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following internalization, tetanus toxin gets transported in a retrograde way from the peripheral nervous system to the central nervous system by retrograde axonal transport. When tetanus toxin reaches inhibitory neuron terminals, it prevents the presynaptic release of inhibitory neurotransmitters glycine and gamma-aminobutyric acid (GABA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Incubation period of tetanus is about 6-10 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-50.jpg\" alt=\"\" width=\"400\" height=\"219\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical features -</strong> Patients have prolonged muscle spasms of both flexor and extensor muscles. Patients with tetanus have spastic muscle contractions, difficulty opening the jaw (called lockjaw, <strong>“trismus</strong>”), a characteristic smile called “<strong>risus sardonicus</strong>” and contractions of back muscles resulting in backward arching (<strong>Opisthotonos </strong>position). Patients are extremely irritable, and tetanic seizures develop, brought about by violent, painful muscle contractions following some minor stimulus, such as noise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Presynaptic inhibition of Ach receptors</strong>: This mechanism is not involved in the action of tetanospasmin. It is more relevant to the action of botulinum toxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Postsynaptic inhibition of GABA</strong>: This is not the mechanism of action for tetanospasmin. Tetanospasmin acts presynaptically.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cleavage of SNARE proteins, preventing Ach release</strong>: This describes the mechanism of action of botulinum toxin, not tetanospasmin. Botulinum toxin cleaves SNARE proteins, which prevents the release of acetylcholine (Ach) at the neuromuscular junction, leading to flaccid paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tetanospasmin, the toxin responsible for tetanus, acts by inhibiting the presynaptic release of the inhibitory neurotransmitters GABA and glycine, leading to unopposed muscle contraction and the characteristic symptoms of tetanus, such as muscle spasms and opisthotonos.</span></p>",
      "correct_choice_id": 16243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24745,
      "choices": [
        {
          "id": 98941,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-U3 RNP</span></span></span></p>"
        },
        {
          "id": 98942,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-centromere antibody</span></span></span></p>"
        },
        {
          "id": 98943,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-PM-Scl antibody</span></span></span></p>"
        },
        {
          "id": 98944,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Jo-1 antibody</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman, 35 years old, arrives with symptoms of skin thickening, weakened muscles, and paleness in the extremities when exposed to cold temperatures. Her ANA and anti-Scl-70 antibody tests yield positive results. Elevated levels of creatinine kinase are observed, and a muscle biopsy reveals perifascicular infiltration. Which antibody is linked to these findings?</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
      "unique_key": "Q9147109",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794194,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Anti-PM-Scl antibody </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given patient presenting symptoms that indicate diffuse systemic sclerosis and dermatomyositis/polymyositis, is highly probable to have an overlap syndrome [Combinations of three connective tissue diseases, i.e., systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS) and&nbsp;polymyositis&nbsp;(PM) or&nbsp;dermatomyositis&nbsp;(DM)].</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-PM-Scl antibodies are characteristically found in patients with overlap syndromes, which involve features of systemic sclerosis combined with polymyositis or dermatomyositis. These overlap syndromes involve a combination of autoimmune conditions, often including systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and polymyositis (PM) or dermatomyositis (DM).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Anti-U3 RNP</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anti-U3 RNP antibodies are typically associated with systemic sclerosis but can be found in both limited and diffuse forms of the disease. They are not specifically linked to the overlap syndrome seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Anti-centromere antibody</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anti-centromere antibodies are most commonly associated with limited systemic sclerosis (CREST syndrome), not the diffuse form or the overlap syndrome involving myositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Anti-Jo-1 antibody</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anti-Jo-1 antibodies are strongly associated with polymyositis and dermatomyositis, particularly with lung involvement, but they are less common than Anti-PM-Scl antibodies in patients with overlap syndromes involving systemic sclerosis and myositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-PM-Scl antibodies are commonly associated with overlap syndromes involving systemic sclerosis and myositis, making them the likely antibody in patients presenting with features of both conditions.</span></span></span></p>",
      "correct_choice_id": 98943,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10048,
      "choices": [
        {
          "id": 40158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 40159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        },
        {
          "id": 40160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
        },
        {
          "id": 40161,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 55-year-old chronic smoker presents to the OPD with complaints of shortness of breath and cough. A mass is noted at the lower lobe periphery of the lung. A diagnosis of lung adenocarcinoma is made. What will be the biopsy finding? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thyroid transcription factor-1</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P40</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Napsin A</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromogranin</span></span></span></li>\r\n</ol>",
      "unique_key": "Q3912099",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) 1, 3</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the context of lung adenocarcinoma, particularly in a chronic smoker presenting with a peripheral lung mass, specific markers on the biopsy can confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Thyroid transcription factor-1 (TTF-1)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TTF-1 is a nuclear transcription factor commonly expressed in lung adenocarcinoma and is used as a diagnostic marker to differentiate primary lung adenocarcinoma from other types of lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Napsin A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Napsin A is another marker often expressed in lung adenocarcinoma, associated with the protein&#39;s role in the proteolytic processing of surfactant precursors in the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These markers are both used to identify lung adenocarcinoma, particularly in cases where the tumor presents in the lung periphery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. P40</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: P40 is a marker associated with squamous cell carcinoma of the lung, not adenocarcinoma. Its presence would suggest a different subtype of lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Chromogranin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Chromogranin is a marker used in neuroendocrine tumors, such as small cell lung cancer, and is not typically found in lung adenocarcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113157_j7U5sRU.jpg\" style=\"height:747px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 40158,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51012,
      "choices": [
        {
          "id": 203581,
          "text": "<p><span style=\"font-size:12pt;\">ii and iv</span></p>"
        },
        {
          "id": 203582,
          "text": "<p><span style=\"font-size:12pt;\">i, ii, and iv</span></p>"
        },
        {
          "id": 203583,
          "text": "<p><span style=\"font-size:12pt;\">i and iii</span></p>"
        },
        {
          "id": 203584,
          "text": "<p><span style=\"font-size:12pt;\">iii and iv</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The fibres of the internal oblique muscle and transversus abdominus muscle contribute to which boundaries of the inguinal canal walls? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12pt;\">Anterior wall</span></li><li><span style=\"font-size:12pt;\">Roof</span></li><li><span style=\"font-size:12pt;\">Floor</span></li><li><span style=\"font-size:12pt;\">Posterior wall</span></li></ol>",
      "unique_key": "Q9466938",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794190,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) ii and iv</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-03-170131.png\" alt=\"\" width=\"600\" height=\"326\"></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/whatsapp-image-2024-07-04-at-123537-pm.jpeg\" alt=\"\" width=\"500\" height=\"432\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The inguinal canal is an important structure in the anterior abdominal wall, with specific boundaries formed by different layers of muscles and fascia. The internal oblique is present in the lateral 1/3rd of anterior wall but transverse abdominis does not contribute to the anterior wall at all.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>ii. Roof:</strong> The fibres of the internal oblique and transversus abdominis muscles, along with their conjoint tendon, form the roof of the inguinal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>iv. Posterior wall:</strong> The conjoint tendon, formed by the joining of the internal oblique and transversus abdominis muscles, also contributes to the posterior wall of the inguinal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>i. Anterior wall:</strong> The anterior wall of the inguinal canal is primarily formed by the external oblique aponeurosis, along with skin and superficial fascia. The internal oblique and transversus abdominis muscles do not contribute to the anterior wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>iii. Floor:</strong> The floor of the inguinal canal is formed by the inguinal ligament, not by the internal oblique or transversus abdominis muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The internal oblique and transversus abdominis muscles contribute to the roof and posterior wall of the inguinal canal through their conjoint tendon.</span></p>",
      "correct_choice_id": 203581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73664,
      "choices": [
        {
          "id": 293597,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-2, D-1</span></p>"
        },
        {
          "id": 293598,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-4, D-3</span></p>"
        },
        {
          "id": 293599,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-1, D-4</span></p>"
        },
        {
          "id": 293600,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-1, C-3, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Match the following: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cnJyaL0.png\" width=\"1104\" height=\"283\"></span></p>",
      "unique_key": "Q5488564",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794112,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) A-3, B-4, C-2, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Mitochondrial inheritance (A) is associated with Leber's disease (3).</strong> Mitochondrial inheritance, also called <strong>maternal inheritance</strong>, occurs when DNA in the mitochondria is passed from <strong>mother to offspring</strong>. Leber's optic neuropathy is a classic example of a mitochondrial disease transmitted through maternal inheritance. This is because <strong>mitochondrial DNA</strong> is present in the ovum but not in sperm.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Zj04d9v.png\" width=\"644\" height=\"372\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>X-linked recessive inheritance (B) is linked to Duchene's muscular dystrophy (4).</strong> In XLR inheritance, the disease is more common in males since they only have one X chromosome. Duchene's muscular dystrophy is specifically listed as an example of X-linked recessive disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Autosomal recessive inheritance (C) corresponds to cystic fibrosis (2).</strong> AR disorders require two copies of the mutated gene to manifest the disease and are common in consanguineous marriages. Cystic fibrosis is a classic example of an autosomal recessive disorder affecting enzymatic proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Trinucleotide repeat disorders (D) include spinobulbar dystrophy (1).</strong> These disorders are characterized by expansion of nucleotide repeats during gametogenesis, leading to neurological diseases. The unstable expansion of trinucleotide repeats (CAG) causes spinobulbar muscular atrophy (Kennedy disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Genetic Disorders and Their Inheritance Patterns</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1nfl9Rg.png\" width=\"1290\" height=\"335\"></strong></span></p>",
      "correct_choice_id": 293597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5926,
      "choices": [
        {
          "id": 23674,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pap smear</span></span></span></p>"
        },
        {
          "id": 23675,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Visual inspection with iodine</span></span></span></p>"
        },
        {
          "id": 23676,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colposcopy</span></span></span></p>"
        },
        {
          "id": 23677,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old patient with a history of diabetes and hypertension came with post-menopausal bleeding. Which of the following you will do to evaluate the cause?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q2798438",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794119,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Endometrial sampling</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling is done to evaluate a patient presenting with postmenopausal bleeding.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transvaginal ultrasound (TVS) is a better first-line investigation since TVS is not included in the options, endometrial sampling is the next best answer.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both diabetes and hypertension are risk factors for endometrial hyperplasia and carcinoma hence endometrial sampling would be the more appropriate test as compared to tests for cervical cancer screening.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling is indicated in a woman with post-menopausal bleeding with the endometrial thickness is &gt; 4 mm. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pap smear</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A pap smear should be done in all women complaining of post menopausal women with a normal looking cervix and a cervical biopsy for all women with a cervical growth but in this question, based on risk factors, we are more worried about endometrial cancer and hence endometrial sampling is a better option. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Visual inspection with iodine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is not the preferred option and even if cervical cancer screening is warranted, a pap smear or HPV is better. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colposcopy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is indicated if there is any cytological abnormality on the pap smear</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling is done to evaluate a patient presenting with postmenopausal bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 560, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition.</span></strong></span></span></p>",
      "correct_choice_id": 23677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14368,
      "choices": [
        {
          "id": 57433,
          "text": "<p><span style=\"font-size:12.0pt;\">GIST</span></p>"
        },
        {
          "id": 57434,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 57435,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin’s lymphoma</span></p>"
        },
        {
          "id": 57436,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female patient presents to the hospital with complaints of abdominal pain and discomfort for the past few months. The patient also reported experiencing weight loss and loss of appetite. On evaluation, a mass is palpable in the upper abdomen, and an endoscopy shows an ulcerated lesion in the stomach. A biopsy of the lesion is taken and sent for immunohistochemistry. The biopsy sample is found to be positive for CD117 and negative for LCA, cytokeratin, and S100. Based on these findings. What is the most likely diagnosis?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9968504",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794203,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) GIST</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and the biopsy results suggest the possibility of gastrointestinal stromal tumors (GIST). GIST is the most common mesenchymal tumor of the abdomen, and it typically arises from the interstitial cells of Cajal or the pacemaker cells of the gastrointestinal muscularis propria. GISTs are often associated with symptoms of mass effect, such as abdominal pain and discomfort, and can lead to weight loss and loss of appetite. The diagnosis of GIST is confirmed by immunohistochemistry, which typically shows positivity for KIT (CD117) detectable in Cajal cells. Other immunohistochemical markers such as LCA, cytokeratin, and S100 are negative. Treatment options for GIST may include surgery, radiation therapy, or targeted therapy with tyrosine kinase inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenocarcinoma</strong>: Adenocarcinoma is a common type of cancer that can occur in various organs, including the stomach. However, the immunohistochemistry findings mentioned in the question (positive for CD117 and negative for LCA, cytokeratin, and S100) are not characteristic of adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hodgkin’s lymphoma</strong>: Hodgkin's lymphoma is a type of lymphoma that typically presents with enlarged lymph nodes and is characterized by the presence of Reed-Sternberg cells. The immunohistochemistry findings mentioned in the question are not consistent with Hodgkin's lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Squamous cell carcinoma</strong>: Squamous cell carcinoma is commonly associated with the epithelial lining of organs, and its diagnosis would typically involve positive staining for cytokeratin. The immunohistochemistry findings mentioned in the question (negative for cytokeratin) do not support the diagnosis of squamous cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GISTs are mesenchymal tumors that typically occur in the gastrointestinal tract. They often express CD117 (c-kit), a marker commonly associated with GIST. The negative staining for LCA (Leukocyte Common Antigen), cytokeratin, and S100 helps rule out other possibilities and supports the diagnosis of GIST.</span></p>",
      "correct_choice_id": 57433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54284,
      "choices": [
        {
          "id": 216605,
          "text": "<p><span style=\"font-size:12.0pt;\">Soft tissue tumour in orbit</span></p>"
        },
        {
          "id": 216606,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid eye disease</span></p>"
        },
        {
          "id": 216607,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve meningioma</span></p>"
        },
        {
          "id": 216608,
          "text": "<p><span style=\"font-size:12.0pt;\">Cavernous hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of proptosis in a middle-aged person?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3439441",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794122,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thyroid eye disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of proptosis in a middle-aged person is thyroid eye disease, also known as Graves' ophthalmopathy. This condition is associated with autoimmune thyroid disease, where the body's immune system mistakenly attacks the tissues around the eyes, leading to inflammation and swelling. This results in the characteristic bulging of the eyes, known as proptosis or exophthalmos.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroid eye disease is particularly common in middle-aged individuals and can cause both unilateral (one eye) and bilateral (both eyes) proptosis. The pathophysiology involves the expansion of the extraocular muscles and increased orbital fat, leading to the protrusion of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Soft tissue tumour in orbit</strong>: While soft tissue tumors in the orbit can cause proptosis, they are not the most common cause in middle-aged individuals. These tumors can be benign or malignant and require imaging studies for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Optic nerve meningioma</strong>: This type of tumor is associated with neurofibromatosis type 2 (NF2) and can lead to proptosis. However, it is less common compared to thyroid eye disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Cavernous hemangioma</strong>: Although cavernous hemangioma is the most common orbital tumor in adults, it is not the most common cause of proptosis. These benign vascular tumors can cause proptosis if they become large enough to displace the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of proptosis in a middle-aged person is thyroid eye disease (Graves' ophthalmopathy).</span></p>",
      "correct_choice_id": 216606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34052,
      "choices": [
        {
          "id": 136043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 4 </span></span></span></p>"
        },
        {
          "id": 136044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1,2,3</span></span></span></p>"
        },
        {
          "id": 136045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1,3,4</span></span></span></p>"
        },
        {
          "id": 136046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2,3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">First part of PCT has which of the following transport proteins? (</span></span></span>INICET Nov 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium potassium pump</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na- glucose co-transporter</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium hydrogen antiport</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na<sup>+</sup> Bicarbonate cotransporter </span></span></span></li>\r\n</ol>",
      "unique_key": "Q5092745",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 1,2,3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Sodium-potassium pump:</span></strong><span style=\"font-size:12.0pt\"> This transporter is found on the basolateral side of the proximal convoluted tubule (PCT) cells and is critical for maintaining the sodium gradient that drives other transport processes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Na-glucose co-transporter:</span></strong><span style=\"font-size:12.0pt\"> This is located on the apical membrane of PCT cells and uses the sodium gradient to co-transport glucose from the tubular lumen into the cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Sodium-hydrogen antiport:</span></strong><span style=\"font-size:12.0pt\"> Also on the apical membrane, this antiporter exchanges sodium from the tubular lumen with hydrogen ions from the cell, playing a key role in sodium reabsorption and pH balance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Option</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Na+ Bicarbonate cotransporter:</span></strong><span style=\"font-size:12.0pt\"> It is present in the distal or late part of PCT (Not in the early PCT)- contributes to bicarbonate reabsorption.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct combination based on the provided answer is b) 1,2,3, which includes the sodium-potassium pump, the Na-glucose co-transporter, and the sodium-hydrogen antiport, all of which are essential for the function of the PCT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proximal convoluted tubule &ndash; transport processes &ndash; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/14.jpg\" style=\"height:291px; width:1000px\" /></p>",
      "correct_choice_id": 136044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6088,
      "choices": [
        {
          "id": 24321,
          "text": "<p><span style=\"font-size:12pt;\">Platinum resistant if recurrence &gt; 12 months</span></p>"
        },
        {
          "id": 24322,
          "text": "<p><span style=\"font-size:12pt;\">Partial platinum resistant if recurrence is within 6-12 months</span></p>"
        },
        {
          "id": 24323,
          "text": "<p><span style=\"font-size:12pt;\">Platinum sensitive if recurrence &gt; 6 months of starting primary therapy</span></p><p>&nbsp;</p>"
        },
        {
          "id": 24324,
          "text": "<p><span style=\"font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the treatment of recurrent ovarian cancer?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q7236054",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794129,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Platinum sensitive if recurrence &gt; 6 months &nbsp;of starting primary therapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Platinum-refractory disease</strong>: This includes women who progress during primary chemotherapy. It has the worst prognosis, as these patients do not respond to platinum-based chemotherapy at all.</span></li><li><span style=\"font-size:12pt;\"><strong>Platinum-resistant disease</strong>: This includes women who relapse within 6 months of completing primary therapy. Bevacizumab has been approved for the treatment of platinum-resistant disease due to its ability to inhibit angiogenesis, which is crucial for tumor growth and metastasis.</span></li><li><span style=\"font-size:12pt;\"><strong>Platinum-sensitive disease</strong>: This includes women who relapse more than 6 months after completing primary therapy. These patients are considered to have a better prognosis and are treated with a platinum-based combination such as carboplatin and paclitaxel or gemcitabine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Platinum resistant if recurrence &gt; 12 months</strong>: This statement is incorrect. If the recurrence occurs more than 12 months after treatment, it is considered platinum-sensitive, not resistant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Partial platinum resistant if recurrence is within 6-12 months</strong>: This statement is not a recognized classification. The classification focuses on the 6-month mark to distinguish between resistant and sensitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Platinum-sensitive recurrent ovarian cancer is characterized by a recurrence occurring more than 6 months after completing primary therapy.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/al-35.jpg\" alt=\"\" width=\"500\" height=\"275\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Berek and Novak’s gynecology 15<sup>th</sup> edition pg 1387</strong></span></p>",
      "correct_choice_id": 24323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50950,
      "choices": [
        {
          "id": 203341,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3&nbsp;</span></p>"
        },
        {
          "id": 203342,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 5&nbsp;</span></p>"
        },
        {
          "id": 203343,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5&nbsp;</span></p>"
        },
        {
          "id": 203344,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man presented with an acute onset of chest pain radiating to the left arm and diaphoresis. His ECG and cardiac biomarkers show non-ST elevation myocardial infarction. Which of the following will be used in the treatment of this patient? (</span>INICET Nov 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Atorvastatin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">2. Aspirin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">3. Clopidogrel&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">4. Low molecular weight heparin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">5. Alteplase</span></p>",
      "unique_key": "Q9418706",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794198,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of non-ST elevation myocardial infarction (NSTEMI), several medications are routinely used to reduce the risk of further ischemic events and manage the condition effectively:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Atorvastatin: High-intensity statin therapy is recommended to lower cholesterol levels and stabilize atherosclerotic plaques.</span></li><li><span style=\"font-size:12.0pt;\">Aspirin: This antiplatelet agent is essential for reducing clot formation and preventing further arterial blockage.</span></li><li><span style=\"font-size:12.0pt;\">Clopidogrel: Another antiplatelet agent, often used in combination with aspirin, to provide dual antiplatelet therapy (DAPT), which is beneficial in preventing further ischemic events.</span></li><li><span style=\"font-size:12.0pt;\">Low molecular weight heparin: Anticoagulant therapy, such as enoxaparin, is crucial in preventing thrombus formation and managing NSTEMI. Enoxaparin is typically administered subcutaneously at a dose of 1 mg/kg twice daily.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. Alteplase: This thrombolytic agent is used in the management of ST-elevation myocardial infarction (STEMI) when percutaneous coronary intervention (PCI) is not immediately available. It is not indicated for NSTEMI due to the lack of ST elevation and the associated risks of bleeding without significant benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For NSTEMI management, the treatment includes Atorvastatin, Aspirin, Clopidogrel, and Low molecular weight heparin. Thrombolytic agents like Alteplase are reserved for STEMI with specific indications.</span></p>",
      "correct_choice_id": 203344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13145,
      "choices": [
        {
          "id": 52541,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 52542,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿1-a, 2-c, 3-d, 4-b</span></p>"
        },
        {
          "id": 52543,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿1-b, 2-a, 3-d, 4-c</span></p>"
        },
        {
          "id": 52544,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿1-d, 2-c, 3-a, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following:(INICET NOV 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-130045.png\" alt=\"\" width=\"700\" height=\"233\"></p>",
      "unique_key": "Q9817831",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794131,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1-b, 2-a, 3-d, 4-c</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1-b: Colour vision - Ishihara chart</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Colour vision</strong> is tested with Ishihara plates, which is a pseudoisochromatic chart. There are patterns of coloured and grey dots that reveal one pattern to persons with normal colour vision and another to those with the colour deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The below image shows a representative plate of the Ishihara chart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_7qyUR70.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Limitation of ischihara chart</strong>: Ischihara chart is useful as a screening tool for colour blindness. It mainly tests for red-green blindness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In order to check blue-yellow blindness other tests such as 100 Hue Test are required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2-a: Intraocular pressure - Applanation tonometer</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An <strong>applanation tonometer</strong> is used to measure the intraocular pressure. It is based on the Imbert-Fick law, which states that the pressure inside a sphere(P) is equal to the force (W) required to flatten its surface divided by the area of flattening (A).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">P = W/A</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following is an image of the applanation tonometer:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_t8ZnLw9.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are two types of applanation tonometers:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(1) In which the surface area of the prism is constant – Eg</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Goldmann Applanation Tonometer (GAT):</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Goldmann tonometer is one of the most widely used and considered the gold standard for measuring intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">It consists of a prism that is gently applied to the anesthetized cornea, flattening a small area.</span></li><li><span style=\"font-size:12.0pt;\">The amount of force required to flatten the cornea is directly related to intraocular pressure.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Perkins Applanation Tonometer:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Perkins tonometer is a handheld, portable device used for measuring intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">It is similar in principle to the Goldmann tonometer but is more compact and easier to transport.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Tono-Pen (Reichert Tonometer):</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Tono-Pen is a handheld electronic applanation tonometer.</span></li><li><span style=\"font-size:12.0pt;\">It works by measuring the force required to flatten the cornea, and the reading is displayed electronically.</span></li><li><span style=\"font-size:12.0pt;\">It is often used in clinical settings due to its ease of use and portability.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(2) Tonometer with constant pressure and variable area – eg. MALAKOFF’S Tonometer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3-d: Peripheral vision - Perimetry</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Perimetry&nbsp;</strong>is a diagnostic procedure used to chart the boundaries of a person's visual field. There are two main types of perimetry: kinetic and static perimetry. Kinetic perimetry involves moving a target with a specific luminance from a non-seeing area in the periphery towards the center until the person perceives it. In contrast, static perimetry involves presenting a stationary stimulus and adjusting its intensity until the person either reaches a threshold of detection or can no longer detect it. One type of static perimetry is <strong>tangent screen perimetry</strong>, which tests the central 30 degrees field at 1 meter and evaluates a person's central vision.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Examples of Kinetic Perimetry – Goldmann perimetry and Bjerrum Perimetry</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Examples of Static Perimetry – Static Automated perimetry – Humphrey Visual Field analyser and Octopus Visual field analyser.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4-c: Central vision - Tangent screen test</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The tangent screen test is a specific method used to assess central visual field up to 30 degrees from fixation. It involves using a black screen and white or colored targets to determine the sensitivity of central vision, particularly useful in detecting central visual field defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Colour vision - <strong>Ishihara chart</strong></span></li><li><span style=\"font-size:12.0pt;\">Intraocular pressure - <strong>Applanation tonometer</strong></span></li><li><span style=\"font-size:12.0pt;\">Peripheral vision - <strong>Perimetry</strong></span></li><li><span style=\"font-size:12.0pt;\">Central vision - <strong>Tangent screen test</strong></span></li></ul>",
      "correct_choice_id": 52543,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2838,
      "choices": [
        {
          "id": 11337,
          "text": "<p><span style=\"font-size:12.0pt;\">Real time PCR</span></p>"
        },
        {
          "id": 11338,
          "text": "<p><span style=\"font-size:12.0pt;\">Conventional PCR with Restriction Fragment Length pair technique</span></p>"
        },
        {
          "id": 11339,
          "text": "<p><span style=\"font-size:12.0pt;\">RT-PCR</span></p>"
        },
        {
          "id": 11340,
          "text": "<p><span style=\"font-size:12.0pt;\">RT-PCR followed by Real time PCR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is more appropriate for quantitative analysis of viral RNA genome?(INICET NOV 2021)</span></p>",
      "unique_key": "Q6422748",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794135,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) RTPCR followed by Real time PCR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">RT-PCR followed by Real time PCR</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">To quantitatively analyze viral RNA genomes, two key processes are required:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Reverse Transcription (RT): Viral RNA must first be converted into complementary DNA (cDNA) because PCR (Polymerase Chain Reaction) can only amplify DNA. This is done using Reverse Transcriptase, hence RT-PCR (Reverse Transcription PCR).</span></li><li><span style=\"font-size:16px;\">Quantification using Real Time PCR (qPCR): Once the cDNA is synthesized, Real-Time PCR is used to quantify the amount of target nucleic acid in real time using fluorescent markers.</span></li></ol><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Thus, for quantitative analysis of viral RNA:</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><ul><li><span style=\"font-size:16px;\"><strong>First step → RT-PCR</strong></span></li><li><span style=\"font-size:16px;\"><strong>Second step → Real-Time PCR (qPCR)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Real Time PCR: </strong>This refers to quantification but only works with DNA, not directly with RNA. Without the reverse transcription step, it cannot quantify viral RNA.</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong>Option B. Conventional PCR with RFLP: </strong>This is qualitative and used for genotyping or mutation detection, not quantitative analysis.</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong>Option C. RT-PCR: </strong>RT-PCR alone allows detection of RNA (qualitative), but not quantification unless combined with Real-Time PCR.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">RT PCR followed by Real-time PCR is the most appropriate technique for quantitative analysis of viral RNA genomes, allowing real-time monitoring and quantification of&nbsp;viral&nbsp;RNA&nbsp;load.</span></p>",
      "correct_choice_id": 11340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14330,
      "choices": [
        {
          "id": 57281,
          "text": "<p><span style=\"font-size:12.0pt;\">Genetic counselling and screening for BRA</span></p>"
        },
        {
          "id": 57282,
          "text": "<p><span style=\"font-size:12.0pt;\">Routine mammography</span></p>"
        },
        {
          "id": 57283,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop taking oral contraceptive pills</span></p>"
        },
        {
          "id": 57284,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylactic surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman with a family history of breast and ovarian cancer is seeking advice about her risk for developing breast cancer. She is currently taking oral contraceptive pills and is concerned about her risk. Which of the following is the next best step in management?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q8940182",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794121,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Genetic counselling and screening for BRA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A family history of breast and ovarian cancer in close relatives with one of the relatives having an onset before the age of 50 years indicates a high risk for breast cancer.</span></li><li><span style=\"font-size:12.0pt;\">The next step in management is genetic counselling and screening for BRA.</span></li><li><span style=\"font-size:12.0pt;\">This involves discussing various genetic testing options such as BRCA testing and multiple gene panel testing.</span></li><li><span style=\"font-size:12.0pt;\">Genetic testing is recommended for high-risk women with a family history of breast or ovarian cancer, particularly if the diagnosis was made before age 50, if there are multiple affected family members, or if the patient has a personal history of breast or ovarian cancer.</span></li><li><span style=\"font-size:12.0pt;\">Mammography is not the initial investigation of choice but can be used for surveillance after genetic screening.</span></li><li><span style=\"font-size:12.0pt;\">Discontinuing oral contraceptive pills is not necessary as they do not increase the risk of breast cancer in women with a positive family history of breast cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the patient's family history of breast and ovarian cancer, as well as her concerns about her risk, the next best step is to offer genetic counseling and testing for BRCA1 and BRCA2 mutations. These genetic mutations are associated with an increased risk of breast and ovarian cancer. Understanding her genetic risk can help the patient make informed decisions about her healthcare, including potential surveillance and risk-reduction strategies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Routine</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>mammography</strong>: Routine mammography is a screening tool for breast cancer, but it is typically recommended for women starting at around age 40 or 50, depending on guidelines and individual risk factors. While it's an important part of breast cancer screening, it may not be the most appropriate initial step in this case, given the patient's family history and concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stop taking oral contraceptive</strong> <strong>pills</strong>: While hormonal factors can be associated with a slight increase in breast cancer risk, discontinuing oral contraceptive pills may not be the primary step in managing a patient with a strong family history of breast and ovarian cancer. Genetic counseling and testing for BRCA mutations would provide more specific information about her risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prophylactic surgery</strong>: Prophylactic surgery, such as a bilateral mastectomy or oophorectomy, may be considered in individuals with known BRCA mutations who have a high risk of breast and ovarian cancer. However, this step would be taken after genetic counseling and testing to determine the patient's risk and suitability for such procedures. It is not the initial step in management.</span></p>",
      "correct_choice_id": 57281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54509,
      "choices": [
        {
          "id": 217505,
          "text": "<p><span style=\"font-size:12.0pt;\">Reed Sternberg cells are of B cell origin</span></p>"
        },
        {
          "id": 217506,
          "text": "<p><span style=\"font-size:12.0pt;\">Reed Sternberg cells are CD30+ and PAX 5+</span></p>"
        },
        {
          "id": 217507,
          "text": "<p><span style=\"font-size:12.0pt;\">Nodular sclerosis HL commonly involves the mediastinum</span></p>"
        },
        {
          "id": 217508,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonest site for HL is the Waldeyer ring</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an incorrect statement about Hodgkin lymphoma (HL) ?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7189213",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794108,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Commonest site for HL is the Waldeyer ring</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hodgkin lymphoma (HL) is characterized by the presence of Reed Sternberg cells, which are of B cell origin. These cells typically express CD30 and PAX 5 markers. The nodular sclerosis subtype of HL often involves the mediastinum, where Reed Sternberg cells are referred to as lacunar cells due to their unique appearance in this subtype. However, the statement that the commonest site for HL is the Waldeyer ring is incorrect. The Waldeyer ring is more commonly involved in non-Hodgkin lymphoma (NHL). HL typically affects the cervical, mediastinal, axillary, and inguinal lymph nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Reed Sternberg cells are of B cell origin:&nbsp;</strong>Correct. Reed Sternberg cells, the hallmark of Hodgkin lymphoma, originate from B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Reed Sternberg cells are CD30+ and PAX 5+:&nbsp;</strong>Correct. Reed Sternberg cells express CD30 and PAX 5 markers, which are used in diagnosing Hodgkin lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nodular sclerosis HL commonly involves the mediastinum:&nbsp;</strong>Correct. The nodular sclerosis subtype of Hodgkin lymphoma frequently involves the mediastinum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hodgkin lymphoma typically involves the cervical, mediastinal, axillary, and inguinal lymph nodes. The involvement of the Waldeyer ring is more characteristic of non-Hodgkin lymphoma</span></p>",
      "correct_choice_id": 217508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54794,
      "choices": [
        {
          "id": 218641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">NREM 2</span></span></span></p>"
        },
        {
          "id": 218642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">NREM 3</span></span></span></p>"
        },
        {
          "id": 218643,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">NREM 4</span></span></span></p>"
        },
        {
          "id": 218644,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">&nbsp;REM</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the stage of sleep denoted by the arrow: (INICET MAY 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-152214.png\" style=\"height:193px; width:400px\" /></p>",
      "unique_key": "Q1902247",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794114,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) REM</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The stage of sleep indicated by the arrow is REM (Rapid Eye Movement) sleep. This can be identified based on the specific patterns observed in the EEG (Electroencephalogram), EMG (Electromyogram), and EOG (Electrooculogram) readings:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/whatsapp-image-2024-08-26-at-21214-pm.jpeg\" style=\"height:220px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EEG</span></strong><span style=\"font-size:12.0pt\">: The EEG during REM sleep shows low-amplitude, high-frequency waves that are similar to the wakeful state. This pattern is characteristic of REM sleep and is often described as &quot;sawtooth&quot; waves.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EMG</span></strong><span style=\"font-size:12.0pt\">: The EMG during REM sleep shows a flat line, indicating muscle atonia. This muscle atonia is a defining feature of REM sleep, where most of the body&#39;s voluntary muscles are temporarily paralyzed. This prevents the sleeper from acting out their dreams.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EOG</span></strong><span style=\"font-size:12.0pt\">: The EOG during REM sleep shows rapid movements of the eyes, which is where REM sleep gets its name. These rapid eye movements are indicative of the intense brain activity occurring during this stage, despite the body&#39;s overall lack of movement.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In contrast, non-REM (NREM) sleep stages (including NREM 2, 3, and 4) show different patterns:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NREM stages generally have higher amplitude, lower frequency EEG patterns.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Muscle tone is reduced but not absent as in REM sleep.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eye movements are either slow or absent, depending on the specific NREM stage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. NREM 2</span></strong><span style=\"font-size:12.0pt\">: This stage of sleep is characterized by sleep spindles and K-complexes on the EEG, with reduced but not absent muscle tone and minimal eye movement. The patterns described in the question do not match this stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. NREM 3</span></strong><span style=\"font-size:12.0pt\">: Known as slow-wave sleep or deep sleep, NREM 3 is characterized by high-amplitude, low-frequency delta waves on the EEG. Muscle tone is decreased but not completely absent, and there is minimal to no eye movement. The pattern described does not correspond to NREM 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. NREM 4</span></strong><span style=\"font-size:12.0pt\">: Often combined with NREM 3 in the modern classification, this stage is also characterized by delta waves, reduced muscle tone, and lack of eye movement. The described pattern is inconsistent with this stage as well.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">REM sleep is characterized by low-amplitude, high-frequency EEG waves, muscle atonia as shown in the EMG, and rapid eye movements as shown in the EOG. Recognizing these patterns is crucial for correctly identifying REM sleep, which is a critical stage for processes like memory consolidation and emotional regulation.</span></span></span></p>",
      "correct_choice_id": 218644,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11755,
      "choices": [
        {
          "id": 46986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders</span></span></span></span></p>"
        },
        {
          "id": 46987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactic acidosis</span></span></span></span></p>"
        },
        {
          "id": 46988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic ketoacidosis</span></span></span></span></p>"
        },
        {
          "id": 46989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salicylate poisoning</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap acidosis with low bicarbonate levels is seen in all the following conditions except: (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q5808368",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal Disorders</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis (HAGMA) is characterized by the accumulation of acids in the body, which are not accompanied by an increase in other measured anions, thus increasing the anion gap. This condition typically involves a decrease in bicarbonate as the body tries to buffer the excess hydrogen ions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lactic Acidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition occurs when lactate levels increase in the bloodstream during tissue hypoxia, commonly seen in shock or severe dehydration, and results in HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diabetic Ketoacidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In DKA, the body produces high levels of blood acids called ketones, which lead to HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Salicylate Poisoning</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In salicylate toxicity, especially at higher doses, metabolic acidosis occurs due to uncoupling of oxidative phosphorylation, leading to HAGMA. Initially, salicylate stimulates the respiratory center causing a respiratory alkalosis, which can be followed by metabolic acidosis at higher doses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders typically cause non-anion gap metabolic acidosis (NAGMA) due to an inability to excrete acid or conserve bicarbonate, rather than high anion gap acidosis seen in conditions like lactic acidosis, diabetic ketoacidosis, and salicylate poisoning.</span></span></span></span></p>",
      "correct_choice_id": 46986,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32749,
      "choices": [
        {
          "id": 130846,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hip Circumference</span></span></span></p>"
        },
        {
          "id": 130847,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        },
        {
          "id": 130848,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></span></p>"
        },
        {
          "id": 130849,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is not considered in the diagnosis of Metabolic syndrome: (</span></span></span>INICET Nov 2023)</p>",
      "unique_key": "Q7002125",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Hip Circumference</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hip circumference </strong>is not typically considered as a diagnostic criterion for metabolic syndrome. The criteria for diagnosing metabolic syndrome usually include a combination of factors such as central obesity (usually measured by waist circumference), elevated blood pressure, elevated fasting glucose, high triglycerides, and low high-density lipoprotein (HDL) cholesterol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HDL (High-Density Lipoprotein):</strong> HDL cholesterol is considered in the diagnosis of metabolic syndrome. Low levels of HDL are one of the criteria for diagnosing metabolic syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose:</strong> Elevated fasting glucose or impaired glucose tolerance is one of the criteria for diagnosing metabolic syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypertension:</strong> High blood pressure is one of the criteria for diagnosing metabolic syndrome. Hypertension is considered a component of metabolic syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes. The diagnosis of metabolic syndrome involves the assessment of specific criteria related to various health parameters. The objective is to identify individuals at higher risk for these conditions so that preventive measures can be taken.</span></span></p>",
      "correct_choice_id": 130846,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48989,
      "choices": [
        {
          "id": 195531,
          "text": "<p><span style=\"font-size:12.0pt;\">Venous bleeding</span></p>"
        },
        {
          "id": 195532,
          "text": "<p><span style=\"font-size:12.0pt;\">Neovascularization of disc</span></p>"
        },
        {
          "id": 195533,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal hemorrhages</span></p>"
        },
        {
          "id": 195534,
          "text": "<p><span style=\"font-size:12.0pt;\">Microaneurysm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In evaluating a patient with nonproliferative diabetic retinopathy (NPDR), which of the following findings would be atypical for a classification of 'very severe’? (INICET Nov 2023)</span></p>",
      "unique_key": "Q3296847",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794116,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neovascularization of disc</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In evaluating a patient with nonproliferative diabetic retinopathy (NPDR), it is important to understand the typical and atypical findings associated with the disease severity:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is considered an atypical finding for NPDR and is generally associated with proliferative diabetic retinopathy (PDR). NVD indicates a more severe and advanced stage where new blood vessels grow on the optic disc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Venous Bleeding</strong>: In NPDR, more common findings are microaneurysms or dot hemorrhages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Retinal Hemorrhages</strong>: Common in NPDR, especially as the severity increases. These hemorrhages are often small and scattered throughout the retina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Microaneurysm</strong>: A hallmark and typically one of the earliest signs of NPDR. These are small, round, red spots seen on fundoscopic examination caused by capillary dilatation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When examining a patient with diabetic retinopathy, finding neovascularization would necessitate reclassification to proliferative diabetic retinopathy, which requires different management strategies including possible laser therapy or anti-VEGF injections to prevent further vision loss.</span></p>",
      "correct_choice_id": 195532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23243,
      "choices": [
        {
          "id": 92936,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 92937,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 3</span></p>"
        },
        {
          "id": 92938,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, and 4</span></p>"
        },
        {
          "id": 92939,
          "text": "<p><span style=\"font-size:12.0pt;\">Only 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the cause(s) that result in non-scarring alopecia from the following options: (</span>INICET May 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Alopecia areata</span></li><li><span style=\"font-size:12.0pt;\">Telogen effluvium</span></li><li><span style=\"font-size:12.0pt;\">Androgenic alopecia</span></li><li><span style=\"font-size:12.0pt;\">Frontal fibrosing alopecia</span></li></ol>",
      "unique_key": "Q5391259",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794107,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Non-scarring alopecia</strong> is characterized by hair loss without destruction of the hair follicle, allowing for the potential regrowth of hair. The options provided include three conditions that typically result in non-scarring alopecia:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Alopecia areata</strong>: An autoimmune disorder that causes patchy hair loss on the scalp and other parts of the body. This condition is non-scarring, as the hair follicles are not destroyed and hair can regrow if the underlying autoimmune process is controlled or subsides.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Telogen effluvium</strong>: A condition characterized by widespread thinning of the hair, often triggered by a significant stress event, illness, or hormonal change. It results from a large number of hair follicles entering the resting phase (telogen) simultaneously. Recovery is possible once the triggering event is resolved, and the follicles remain intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Androgenic alopecia</strong>: Commonly known as male or female pattern baldness, this is a genetic condition influenced by androgens (hormones). It involves hair thinning in a characteristic pattern and is non-scarring, as the hair follicles gradually produce thinner, shorter hairs but are not completely destroyed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Frontal fibrosing alopecia</strong> is a form of scarring alopecia. It involves a progressive, symmetrical band of hair loss at the front of the scalp along with loss of eyebrows. The scarring means that the hair follicles are permanently destroyed, preventing the regrowth of hair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-182828.png\" alt=\"\" width=\"1000\" height=\"601\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-182935.png\" alt=\"\" width=\"1000\" height=\"590\"></p>",
      "correct_choice_id": 92937,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14042,
      "choices": [
        {
          "id": 56129,
          "text": "<p><span style=\"font-size:12.0pt;\">60 degrees</span></p>"
        },
        {
          "id": 56130,
          "text": "<p><span style=\"font-size:12.0pt;\">70 degrees</span></p>"
        },
        {
          "id": 56131,
          "text": "<p><span style=\"font-size:12.0pt;\">80 degrees</span></p>"
        },
        {
          "id": 56132,
          "text": "<p><span style=\"font-size:12.0pt;\">90 degrees</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are working as an ER physician, and a patient with a laceration has just been brought in. You decide to use the interrupted suturing technique to close the wound. As you prepare to suture, you recall that the angle of needle placement is crucial for optimal wound closure. What is the correct angle of needle placement for interrupted suturing technique? (INICET MAY 2021)</span></p>",
      "unique_key": "Q2430656",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794110,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 90 degrees</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct angle because inserting the needle perpendicular to the skin (at a 90-degree angle) ensures optimal tissue eversion and approximation of the wound edges. It allows for consistent depth and distance from the wound edge on both the entry and exit points of the needle, which is crucial for the interrupted suturing technique to effectively close the wound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To properly execute interrupted sutures, it is recommended that the needle is inserted and exited the skin at a right angle (90 degrees). It is important to rotate the needle through the tissue to prevent unnecessary enlargement of the needle hole. The distance between the entry point of the suture and the edge of the wound should be nearly equal to the depth of tissue that is being sutured. Additionally, it is advised to leave a distance that is twice this measurement between two consecutive sutures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-141645.png\" alt=\"\" width=\"400\" height=\"331\"></span></p>",
      "correct_choice_id": 56132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13762,
      "choices": [
        {
          "id": 55009,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-3, C-2, D-4</span></span></p>"
        },
        {
          "id": 55010,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-4, C-1, D-2</span></span></p>"
        },
        {
          "id": 55011,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-1, D-4</span></span></p>"
        },
        {
          "id": 55012,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-4, D-1</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following:</span></span>(INICET MAY 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/screenshot-2023-10-28-190216.jpg\" style=\"height:319px; width:700px\" /></span></span></p>",
      "unique_key": "Q6956126",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794205,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) A-3, B-2, C-1, D-4</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The chronology of eruption of secondary dentition or permanent teeth is as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Canine:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 11-12 years (A-3)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lateral incisor:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 8-9 years (B-2)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">First molar:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 6-7 years (C-1)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Third molar:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 17-25 years (D-4)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronology of eruption of secondary dentition or permanent teeth:</span></span></strong><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/screenshot-2023-10-28-190347.jpg\" style=\"height:861px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mnemonic: <strong>M</strong>other <strong>I</strong>s <strong>I</strong>n <strong>P</strong>ain <strong>P</strong>apa <strong>C</strong>an <strong>M</strong>ake <strong>M</strong>edicine</span></span></span></p>",
      "correct_choice_id": 55011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6039,
      "choices": [
        {
          "id": 24126,
          "text": "<p><span style=\"font-size:12pt;\">1 or 2 doses</span></p>"
        },
        {
          "id": 24127,
          "text": "<p><span style=\"font-size:12pt;\">2 doses</span></p>"
        },
        {
          "id": 24128,
          "text": "<p><span style=\"font-size:12pt;\">1 dose</span></p>"
        },
        {
          "id": 24129,
          "text": "<p><span style=\"font-size:12pt;\">3 doses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Recommended HPV vaccination schedule for 9- to 14-year-olds according to WHO SAGE guidelines is:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3093181",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794204,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1 or 2 doses</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Recommended Schedule:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>One or Two-Dose Schedule</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>One dose</strong> is considered sufficient for healthy individuals aged 9–14 years.</span></li><li><span style=\"font-size:16px;\">Alternatively, a <strong>two-dose schedule</strong> may be administered, with the second dose given <strong>6–12 months</strong> after the first.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Key Considerations:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Primary Target Group</strong>: Girls aged <strong>9–14 years</strong>, ideally before the onset of sexual activity.</span></li><li><span style=\"font-size:16px;\"><strong>Immunocompromised Individuals</strong>: Should receive <strong>at least two doses</strong>, and where feasible, <strong>three doses</strong>, regardless of age.</span></li><li><span style=\"font-size:16px;\"><strong>Vaccination of Boys</strong>: While the primary focus is on girls, vaccinating boys is recommended where feasible and affordable to enhance herd immunity and prevent HPV-related diseases in males.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The WHO SAGE guidelines recommend 1 or 2 doses of HPV vaccine for 9- to 14-year-olds.</span></p>",
      "correct_choice_id": 24126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9904,
      "choices": [
        {
          "id": 39582,
          "text": "<p><span style=\"font-size:12pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 39583,
          "text": "<p><span style=\"font-size:12pt;\">Urticaria</span></p>"
        },
        {
          "id": 39584,
          "text": "<p><span style=\"font-size:12pt;\">Maculopapular rash</span></p>"
        },
        {
          "id": 39585,
          "text": "<p><span style=\"font-size:12pt;\">Atopic dermatitis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">What is the skin manifestation seen resulting from drugs used to treat amebic dysentery? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET May 2022)</span></p>",
      "unique_key": "Q1959021",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794115,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Fixed drug eruption</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Among the various medication available, <strong>metronidazole</strong> is drug used to treat <strong>amebic</strong> <strong>dysentery</strong> <strong>most</strong> <strong>frequently</strong> &amp; it is associated with <strong>fixed</strong> <strong>drug</strong> <strong>eruption</strong> (<strong>FDE</strong>), which is a drug-induced skin manifestation.</span></li><li><span style=\"font-size:12pt;\"><strong>Metronidazole can cause maculopapular rashes</strong>, but it also has a higher likelihood of causing a <strong>fixed drug eruption.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Fixed drug eruptions/ reactions are characterized by sharply demarcated, dull red to brown lesions.</strong> They can cause a <strong>burning sensation </strong>and appear on the <strong>lips, hands, legs, face, genitalia, and oral mucosa.</strong></span></li><li><span style=\"font-size:12pt;\">They frequently appear alone or in <strong>small groups</strong> and <strong>return</strong> to the <strong>same spot</strong>. On <strong>re-exposure</strong> to the harmful drug, however, new lesions may develop on various body parts. FDE is a form of <strong>delayed hypersensitivity</strong> reaction. Some of the most frequently prescribed medications that cause FDE are <strong>NSAIDs Tetracyclines and paracetamol.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Urticaria</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While <strong>urticaria (hives)</strong> can be a common reaction to many <strong>drugs</strong>, it is <strong>not</strong> specifically associated with the treatment of <strong>amoebic</strong> <strong>dysentery</strong>.</span></li><li><span style=\"font-size:12pt;\">Urticaria is characterized by raised, often <strong>itchy</strong>, <strong>red</strong> or <strong>skin</strong>-<strong>colored</strong> <strong>wheals</strong> on the surface of the skin as shown below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture2999.jpg\" alt=\"\" width=\"258\" height=\"194\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is usually as an&nbsp;<strong>immediate&nbsp;</strong>hypersensitivity reaction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Maculopapular rash</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A maculopapular rash is a skin change that can occur with many conditions or as a reaction to various drugs.</span></li><li><span style=\"font-size:12pt;\">It is characterized by a&nbsp;<strong>flat</strong>, <strong>red&nbsp;</strong>area on the skin that is covered with small confluent&nbsp;<strong>bumps&nbsp;</strong>as shown in the below image.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3033.jpg\" alt=\"\" width=\"290\" height=\"194\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While this type of rash can be seen with many types of medications, it is <strong>not</strong> the most characteristic skin manifestation resulting from drugs used to treat <strong>amoebic</strong> <strong>dysentery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Atopic dermatitis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Atopic dermatitis is a chronic skin condition characterized by <strong>itchy, inflamed skin</strong>.</span></li><li><span style=\"font-size:12pt;\">It is <strong>not a drug-induced</strong> condition but rather a type of <strong>eczema</strong> that has a strong <strong>genetic</strong> predisposition and is commonly associated with <strong>allergic</strong> diseases.</span></li><li><span style=\"font-size:12pt;\">It is <strong>not</strong> typically associated with amoebic dysentery treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fixed drug eruption</strong> is a skin manifestation commonly associated with the drugs used to treat amoebic dysentery (Metronidazole).</span></li><li><span style=\"font-size:12pt;\">While other skin reactions can occur due to various drugs, fixed drug eruptions are characterized by <strong>recurrent</strong> lesions at the <strong>same</strong> <strong>site</strong> upon <strong>re-exposure</strong> to a particular drug.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 118 page no 118.11-12</strong></span></p>",
      "correct_choice_id": 39582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5984,
      "choices": [
        {
          "id": 23906,
          "text": "<p><span style=\"font-size:12pt;\">Anencephaly</span></p>"
        },
        {
          "id": 23907,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Omphalocele</span></p>"
        },
        {
          "id": 23908,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Cystic hygroma</span></p>"
        },
        {
          "id": 23909,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Encephalocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A doctor tells a 31-year-old woman, who is 20 weeks pregnant, that her baby has a developmental defect. She has come to you for a second opinion. The following US finding is seen. Identify the defect?</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/04/picture9.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
      "unique_key": "Q9594980",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794134,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Anencephaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given ultrasound image shows an open neural tube defect in the calvaria (skull), which is consistent with the diagnosis of anencephaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Anencephaly:</strong> Results from incomplete closure of the neural tube. It can be detected as early as 10 to 11 weeks of gestation.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Ultrasound Signs:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\"><strong>Frog eye sign:</strong> Absence of cranial calvaria with prominent orbits, resembling the face of a frog.</span></li><li><span style=\"font-size:12pt;\"><strong>Shower cap sign:</strong> Absence of the cranium leading to the protrusion of a disorganized mass of brain tissue, resembling a shower cap and giving rise to a characteristic triangular facial appearance.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Prevention:</strong> Can be prevented by pre-conceptional folic acid supplementation (5 mg) for at least 3 months.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Omphalocele:&nbsp;</strong>Congenital herniation of abdominal contents through a defect in the abdominal wall covered by a membrane. It is different from gastroschisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cystic hygroma:&nbsp;</strong>Lymphangioma occurring in the head-neck region.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Encephalocele:</strong> Protrusion of the brain and membranes through a cranial defect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anencephaly is an open neural tube defect characterized by the absence of the cranial calvaria and prominent orbits, detectable by ultrasound as early as 10 to 11 weeks of gestation. It can be prevented with pre-conceptional folic acid supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg 201, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg471</strong></span></p>",
      "correct_choice_id": 23906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7173,
      "choices": [
        {
          "id": 28660,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-1, D-4</span></span></span></span></span></p>"
        },
        {
          "id": 28661,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿A-3, B-4, C-2, D-1</span></span></span></span></span></p>"
        },
        {
          "id": 28662,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿A-1, B-2, C-4, D-3</span></span></span></span></span></p>"
        },
        {
          "id": 28663,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-3, D-2</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following drugs in column A to their site of action in column B?</span></span></span></span></span>(INICET NOV 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-184118.jpg\" style=\"height:235px; width:700px\" /></span></span></span></p>",
      "unique_key": "Q9086305",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794133,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. A-4, B-1, C-3, D-2</span></span></strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct match is as follows:</span></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/screenshot-2024-10-14-180359.jpg\" style=\"height:236px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide is a carbonic anhydrase inhibitor that acts at the proximal convoluted tubules.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsemide is a loop diuretic that acts by inhibiting Na+-K+-2Cl channel at the thick ascending limb of the Loop of Henle.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlorthalidone, a thiazide-like diuretic, inhibits the Na-CI symporter in the distal convoluted tubule. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasopressin, or ADH, is secreted by the posterior pituitary and mainly acts on the collecting duct, and increases the reabsorption of free water. </span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide acts on the proximal convoluted tubule, Torsemide on the thick ascending limb of the loop of Henle, Chlorothiazide on the distal convoluted tubule, and Vasopressin on the collecting duct.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 28663,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33325,
      "choices": [
        {
          "id": 133146,
          "text": "<p><span style=\"font-size:12.0pt;\">ABO incompatibility</span></p>"
        },
        {
          "id": 133147,
          "text": "<p><span style=\"font-size:12.0pt;\">Congestive cardiac failure</span></p>"
        },
        {
          "id": 133148,
          "text": "<p><span style=\"font-size:12.0pt;\">Parvovirus infection</span></p>"
        },
        {
          "id": 133149,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosomal anomalies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Causes of non-immune hydrops fetalis are all except: (INICET NOV 2023)</span></p>",
      "unique_key": "Q2460981",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794128,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) ABO incompatibility</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ABO incompatibility is an immune-mediated cause of hemolytic disease of the newborn, but it is not typically associated with non-immune hydrops fetalis. Non-immune hydrops is often caused by factors other than immune reactions, such as congenital heart defects, infections, or chromosomal anomalies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Congestive cardiac failure: </strong>Congestive cardiac failure can contribute to non-immune hydrops fetalis. Conditions affecting the fetal heart can lead to fluid accumulation, resulting in hydrops.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Parvovirus infection: </strong>Parvovirus infection is a known cause of non-immune hydrops fetalis. Parvovirus can affect the developing fetus and lead to severe anemia, causing fluid accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Chromosomal anomalies: </strong>Chromosomal anomalies, such as Turner syndrome or trisomy 21, are associated with non-immune hydrops fetalis. Abnormalities in fetal development, including those affecting multiple organ systems, can lead to fluid accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the various causes of non-immune hydrops fetalis. Understand that conditions such as congestive cardiac failure, infections (e.g., parvovirus), and chromosomal anomalies can contribute to the development of hydrops in the absence of immune-mediated factors. Be aware that ABO incompatibility is not a typical cause of non-immune hydrops fetalis.</span></p>",
      "correct_choice_id": 133146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14366,
      "choices": [
        {
          "id": 57425,
          "text": "<p><span style=\"font-size:12.0pt;\">Wedge biopsy</span></p>"
        },
        {
          "id": 57426,
          "text": "<p><span style=\"font-size:12.0pt;\">Excision biopsy</span></p>"
        },
        {
          "id": 57427,
          "text": "<p><span style=\"font-size:12.0pt;\">Core needle biopsy</span></p>"
        },
        {
          "id": 57428,
          "text": "<p><span style=\"font-size:12.0pt;\">USG-guided fine-needle aspiration cytology (FNAC)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which biopsy technique is used to diagnose Marjolin ulcer? </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9490602",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794187,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Wedge biopsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wedge biopsy involves the removal of a small, wedge-shaped piece of tissue from the border of an ulcer. This technique is particularly useful in diagnosing Marjolin ulcers because it is the site where squamous cell carcinomas have maximum proliferation, leading to “everted edge”. Marjolin ulcers often develop in areas of previously injured or scarred skin, and a wedge biopsy can provide a representative sample for histopathological examination to confirm the presence of malignancy.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Excision biopsy</strong>: Excision biopsy is the technique of choice for a cervical lymph node pathology, in which the entire lymph node is surgically removed for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Core needle biopsy:&nbsp;</strong>Core needle biopsy is preferred for sampling soft tissue sarcomas, in which a small sample of tissue is removed using a large bore needle for examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. USG-guided fine-needle aspiration cytology (FNAC)</strong>: USG-guided fine-needle aspiration cytology (FNAC) is the technique of choice for a solitary thyroid nodule, in which a small amount of thyroid tissue is aspirated using a thin needle and examined under a microscope.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A wedge biopsy is the preferred and commonly used biopsy technique to diagnose Marjolin ulcers because it allows for the examination of tissue from the ulceration site.</span></p>",
      "correct_choice_id": 57425,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4233,
      "choices": [
        {
          "id": 16909,
          "text": "<p><span style=\"font-size:12.0pt;\">Saccharin test</span></p>"
        },
        {
          "id": 16910,
          "text": "<p><span style=\"font-size:12.0pt;\">Electron microscopy</span></p>"
        },
        {
          "id": 16911,
          "text": "<p><span style=\"font-size:12.0pt;\">Charcoal powder method</span></p>"
        },
        {
          "id": 16912,
          "text": "<p><span style=\"font-size:12.0pt;\">Scintigraphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests cannot be used to assess nasal mucociliary clearance?</span>(INICET MAY 2022)</p>",
      "unique_key": "Q8192365",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794125,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Electron microscopy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Among the given options, electron microscopy will be the least useful in assessing nasal mucociliary clearance.</span></li><li><span style=\"font-size:12.0pt;\">Electron microscopy -&nbsp; can detect structural and functional abnormalities of cilia but do not detect any other abnormalities interfering with nasal mucociliary clearance. It is used to visualize the detailed architecture of cilia, which can help identify defects in ciliary structure responsible for impaired mucociliary transport, but it does not measure the actual transport or clearance function.</span></li></ul><p><img class=\"image_resized\" style=\"aspect-ratio:2000/1125;width:58.03%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6XCQRnJ.png\" width=\"2000\" height=\"1125\"></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Saccharin&nbsp;Test</strong>: This is a straightforward clinical test where a small amount of saccharin is placed on the nasal mucosa, and the time it takes for the subject to taste the sweetness is measured. This time reflects the mucociliary clearance rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Charcoal Powder Method</strong>: Involves placing a small amount of charcoal powder in the nose and timing how long it takes for it to appear in the pharynx, similarly assessing the clearance capability of the mucociliary apparatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Scintigraphy</strong>: This nuclear medicine test uses a small amount of radioactive material to track and record mucociliary transport and clearance, providing both functional and anatomical information about the nasal and sinus mucosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Test for mucociliary clearance is:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Saccharin&nbsp;with or without color test in vivo -&nbsp;&nbsp; Saccharin or another substance is placed in the nose, and the speed of transport into the nasopharynx is measured to calculate mucociliary clearance.</span></li><li><span style=\"font-size:12.0pt;\">Radioisotope transport testing in vivo</span></li><li><span style=\"font-size:12.0pt;\">Measuring ciliary activity in vitro</span></li><li><span style=\"font-size:12.0pt;\">Nasal nitric oxide -&nbsp; Measuring exhaled nasal nitric oxide, which is mostly reduced in primary ciliary dyskinesia, is a good screening test for immotile-cilia syndrome with a good negative predictive value</span></li><li><span style=\"font-size:12.0pt;\">Scintigraphy is the nuclear medicine equivalent of the dye disappearance test to assess functional and anatomic obstruction</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary radioaerosol mucociliary clearance: Mucociliary transport, which is reduced in these patients, can be measured in situ by administering an inhalation aerosol of colloid albumin or colloid sulfur tagged with technetium Tc 99. This test is generally not recommended owing to the high rate of false-positive results.</span></li><li><span style=\"font-size:12.0pt;\">The charcoal method - a very small amount of charcoal is placed behind the head of the inferior turbinate. The pharynx is then observed to detect the presence of charcoal. Less commonly used.</span></li></ul></li></ul>",
      "correct_choice_id": 16910,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10422,
      "choices": [
        {
          "id": 41654,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 41655,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 41656,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 41657,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The hormone that does not play a role in the growth of the fetus is: (INICET NOV 2022)</span></p>",
      "unique_key": "Q6148651",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794201,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Growth hormone.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fetal growth&nbsp;</strong>is a complex process regulated by various hormones, but <strong>growth hormone</strong> does not play a significant role in this process during fetal life. The primary hormones involved in fetal growth include insulin, thyroxine, and glucocorticoids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Insulin:&nbsp;</strong>Insulin is crucial for fetal growth, especially during the third trimester. It plays a key role in promoting the storage of nutrients and the growth of fetal tissues, particularly adipose tissue and muscle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thyroxine:&nbsp;</strong>Fetal production of thyroxine begins around the 12th week of gestation. Thyroxine is vital for the development of the central nervous system and overall growth and differentiation of tissues.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glucocorticoids:&nbsp;</strong>Glucocorticoids are essential towards the end of gestation, particularly for the maturation of organs such as the lungs, liver, and gastrointestinal tract. They help prepare the fetus for life outside the womb by stimulating the production of surfactant in the lungs and facilitating the maturation of other critical systems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Growth Hormone:&nbsp;</strong>Unlike in postnatal life, where growth hormone is a key regulator of growth, its role in fetal growth is minimal. Fetal growth is largely driven by insulin and other growth factors rather than growth hormone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Insulin and Option C. Thyroxine:&nbsp;</strong>Both are crucial for fetal growth, regulating tissue growth and differentiation, especially in the later stages of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glucocorticoids:&nbsp;</strong>These hormones are essential for the maturation of fetal organs before birth, particularly in the liver, lungs, and gastrointestinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Growth hormone does not play a significant role in fetal growth, which is primarily regulated by insulin, thyroxine, and glucocorticoids.</span></p>",
      "correct_choice_id": 41655,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16090,
      "choices": [
        {
          "id": 64320,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery and middle cerebral artery</span></p>"
        },
        {
          "id": 64321,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery and posterior cerebral artery</span></p>"
        },
        {
          "id": 64322,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery and anterior communicating artery</span></p>"
        },
        {
          "id": 64323,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle cerebral artery and posterior cerebral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the blood supply of the structure marked with the arrow in the image below?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/28/whatsapp-image-2023-06-12-at-1901260.jpg\" alt=\"\" width=\"300\" height=\"225\"></p>",
      "unique_key": "Q4880094",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794126,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Anterior cerebral artery and anterior communicating artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corpus callosum is the largest fibre pathway in the brain. The corpus callosum is composed of the rostrum, genu, trunk or body, and splenium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corpus callosum is a large bundle of nerve fibers that connects the two hemispheres of the brain and allows for communication between them. It is supplied with blood by the anterior cerebral artery and the anterior communicating artery, which are both branches of the internal carotid artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anterior cerebral artery supplies blood to the front and top of the brain, including the medial surface of the cerebral hemispheres, which is where the corpus callosum is located. The anterior communicating artery connects the two anterior cerebral arteries and provides additional blood supply to the corpus callosum. Damage to the corpus callosum, such as from a stroke or traumatic brain injury, can disrupt communication between the two hemispheres and lead to a range of neurological symptoms depending on the location and severity of the damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corpus callosum is the major commissural pathway connecting the cerebral hemispheres that receives its blood supply from anterior communicating artery, pericallosal artery, and posterior pericallosal artery”.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">“Pericallosal artery is formed by branches of from anterior and posterior cerebral arteries (Mainly anterior cerebral artery). Pericallosal arteries which are derived from anterior cerebral arteries supply the anterior 4/5th of corpus callosum and posterior 1/5th is supplied by pericallosal artery derived from posterior cerebral artery.”</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Since the arrow is near the posterior end of body answer is ACommA + ACA</span><br><span style=\"font-size:12.0pt;\">If the arrow was near the anterior end, answer will be ACommA + ACA</span><br><span style=\"font-size:12.0pt;\">If the arrow is on splenium, the answer will be ACA + PCA</span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/12.jpg\" alt=\"\" width=\"500\" height=\"331\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp; <img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/13.jpg\" alt=\"\" width=\"500\" height=\"256\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Anterior cerebral artery and middle cerebral artery:</strong> The anterior cerebral artery does supply the corpus callosum, but the middle cerebral artery does not play a significant role in its blood supply.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Anterior cerebral artery and posterior cerebral artery:</strong> While the anterior cerebral artery supplies the corpus callosum, the posterior cerebral artery primarily supplies the posterior parts of the brain, including the occipital lobes. It doesn't contribute significantly to the blood supply of the corpus callosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Middle cerebral artery and posterior cerebral artery:</strong> Neither the middle cerebral artery nor the posterior cerebral artery is the primary supplier of blood to the corpus callosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11.0pt;\">The corpus callosum's blood supply is primarily provided by the anterior cerebral artery, with additional support from the anterior communicating artery. This knowledge is crucial in understanding potential impacts of circulatory issues within the brain, such as strokes, which could affect interhemispheric communication.</span></p>",
      "correct_choice_id": 64322,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24604,
      "choices": [
        {
          "id": 98377,
          "text": "<p><span style=\"font-size:12.0pt;\">Water in stomach</span></p>"
        },
        {
          "id": 98378,
          "text": "<p><span style=\"font-size:12.0pt;\">Washerwoman's hands and feet</span></p>"
        },
        {
          "id": 98379,
          "text": "<p><span style=\"font-size:12.0pt;\">White leathery foam around mouth and nostrils</span></p>"
        },
        {
          "id": 98380,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive diatom test</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An autopsy was performed on a woman who was reportedly discovered near a village lake. Among the listed factors, which one does not indicate drowning prior to death:(INICET MAY 2023)</span></p>",
      "unique_key": "Q6388409",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794123,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Washerwoman's hands and feet</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Washerwoman's hands and feet just indicates that body was immersed in water. It does not specify whether the person died due to drowning or not. It occurs due to infiltration of water into the outer layers of the skin, which will occur irrespective whether the person died due to drowning or the body was thrown in water after death.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-095140.png\" alt=\"\" width=\"300\" height=\"199\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If a body is recovered from water, the there are two different kind of signs to look for:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Signs of Antemortem Drowning:&nbsp;</strong>These will indicate that person died due to drowning.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Signs of Immersion:&nbsp;</strong>These will only indicate that the body was in water.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Signs of Antemortem Drowning (in descending order of accuracy):</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Grass or weeds tightly held in hands (cadaveric Spasm): Surest sign</span></li><li><span style=\"font-size:12.0pt;\">Drowning Froth Over Mouth and Nose and in air passages: Second best sign</span></li><li><span style=\"font-size:12.0pt;\">Emphysema Aquosum (overinflated lungs)</span></li><li><span style=\"font-size:12.0pt;\">Presence of sand / mud etc. in respiratory passages especially in terminal part</span></li><li><span style=\"font-size:12.0pt;\">Diatom test</span></li><li><span style=\"font-size:12.0pt;\">Presence of water especially if mixed with mud / sand etc. in Stomach or intestines</span></li><li><span style=\"font-size:12.0pt;\">Paltauff Haemorrhage (Subpleural Haemorrhage)</span></li><li><span style=\"font-size:12.0pt;\">Gettler’s test</span></li></ul><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Signs of Immersion</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Washerwoman’s hand / feet</span></li><li><span style=\"font-size:12.0pt;\">Cutis anserina=goose skin</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Water in stomach:</strong> This suggests that the person was alive when entering the water and swallowed water, indicating antemortem drowning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. White leathery foam around mouth and nostrils:</strong> This foam, often referred to as \"drowning froth,\" is a strong indicator of antemortem drowning as it forms when water mixes with air and mucus in the airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Positive diatom test:</strong> The presence of diatoms in the organs indicates that the person inhaled water while still alive, allowing these microscopic algae to enter the bloodstream and be deposited in various tissues, thus confirming antemortem drowning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Washerwoman's hands and feet indicate immersion in water but do not specify drowning as the cause of death, unlike other indicators such as water in the stomach, white leathery foam, and a positive diatom test, which strongly suggest antemortem drowning.</span></p>",
      "correct_choice_id": 98378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7086,
      "choices": [
        {
          "id": 28312,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab</span></span></span></p>"
        },
        {
          "id": 28313,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab</span></span></span></p>"
        },
        {
          "id": 28314,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atezolimumab</span></span></span></p>"
        },
        {
          "id": 28315,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cetuximab</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an immune checkpoint inhibitor?&nbsp;</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q1571094",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794202,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Cetuximab&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cetuximab is a monoclonal antibody against EGFR (Epidermal Growth Factor Receptor). It is used in the treatment of Colorectal and Head and Neck Cancers. It is not an immune check point inhibitor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Nivolumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death receptor - 1 (PD-1) and are used for the treatment of advanced melanoma and classical Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pembrolizumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death receptor</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- 1 (PD-1) and are used for the treatment of advanced melanoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Atezolimumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death-ligand - 1 (PDL-1) and is used for the treatment of urothelial, breast and non-small cell lung cancers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important immune check point inhibitors include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ew: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>N</strong>ivolumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rugs: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>D</strong>urvalumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ct: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A</strong>velumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>At</strong>ezolizumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mmune: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>I</strong>pilimumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">heck: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>C</strong>emiplimab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">oint: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>P</strong>embrolizumab</span></span></span></p>",
      "correct_choice_id": 28315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31817,
      "choices": [
        {
          "id": 127138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A</span></span></p>"
        },
        {
          "id": 127139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B</span></span></p>"
        },
        {
          "id": 127140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C</span></span></p>"
        },
        {
          "id": 127141,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the figure shown below, mechanism of action of valproate is best represented by:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/1.jpg\" style=\"height:302px; width:400px\" /></span></span></p>",
      "unique_key": "Q7047263",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794113,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) A</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Mechanisms of Action of Sodium Valproate</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Enhancement of GABA Activity:</strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate increases the levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. This is achieved primarily by stimulating the enzyme glutamic acid decarboxylase that helps in formation of GABA from glutamic acid. Valproate also acts by inhibiting GABA transaminase, the enzyme responsible for GABA breakdown, leading to increased GABA availability.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inhibition of Voltage-Gated Sodium Channels:</strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate modulates voltage-gated sodium channels in the neurons. By prolonging the recovery of these channels from inactivation, valproate reduces the high-frequency repetitive firing of action potentials.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inhibition of T-Type Calcium Channels:</strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate also affects T-type calcium channels, particularly in thalamic neurons. By inhibiting these channels, it reduces the rhythmic cortical discharges that are often seen in absence seizures.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> B represents the mechanism of action of drugs like gabapentin and pregabalin. These act by increasing the release of GABA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> C represents the mechanism of action of tiagabine. It acts by inhibiting the reuptake of GABA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> D is site of action of benzodiazepines like diazepam and lorazepam.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate increases GABA levels by stimulating the enzyme GAD (glutamic acid decarboxylase) to convert glutamate into GABA and by inhibiting GABA transaminase, preventing the breakdown of GABA.</span></span></p>",
      "correct_choice_id": 127138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23165,
      "choices": [
        {
          "id": 92623,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 only</span></p>"
        },
        {
          "id": 92624,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4 only</span></p>"
        },
        {
          "id": 92625,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 92626,
          "text": "<p><span style=\"font-size:12.0pt;\">1 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the indicators that suggest CPR is of high quality? (</span>INICET May 2023)</p><p>&nbsp;</p><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">1. Chest compression at a rate of 100-120/minute</span></p><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">2. Breathing rate of 20-25/minute</span></p><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">3. Depth of compression should be 5-6 cm</span></p><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">4. Allow chest recoil</span></p>",
      "unique_key": "Q9415352",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794132,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 3, 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>High-Quality CPR Indicators:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Chest Compression Rate:</strong> Chest compressions should be performed at a rate of 100-120 compressions per minute.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Depth of Compression:</strong> Compressions should have a depth of 5-6 centimeters (2-2.4 inches).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Chest Recoil:</strong> It is essential to allow the chest to fully recoil after each compression to ensure adequate filling of the heart between compressions. If an advanced airway, such as an endotracheal tube or supraglottic airway device, is in place, the recommended ventilation rate is 10 breaths per minute.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 2, 3 only: </strong>While a compression depth of 5-6 cm is correct, a breathing rate of 20-25/minute is not part of the indicators for high-quality CPR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 1, 2, 3, 4: </strong>Although chest compression rate, depth, and recoil are correct indicators, the breathing rate of 20-25/minute is not recommended for high-quality CPR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 1 only: </strong>While the correct chest compression rate is part of high-quality CPR, other factors like compression depth and chest recoil are also crucial.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Effective CPR involves chest compressions performed at a rate between 100 to 120 compressions per minute and at a depth of 5 to 6 centimeters, allowing the chest to fully recoil after each compression. The recommended compression-to-ventilation ratio is 30:2 without an advanced airway, and 10 breaths per minute if an advanced airway is in place.</span></li></ul>",
      "correct_choice_id": 92624,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14397,
      "choices": [
        {
          "id": 57549,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic, right colic and branch of middle colic</span></p>"
        },
        {
          "id": 57550,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic, right colic, stem of middle colic, left colic</span></p>"
        },
        {
          "id": 57551,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic, right colic and trunk of middle colic</span></p>"
        },
        {
          "id": 57552,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle colic only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient has been diagnosed with proximal transverse colon carcinoma. The physician recommends an extended right colectomy as a treatment option. Which arteries should be resected during an extended right colectomy to prevent the spread of cancer in proximal transverse colon carcinoma? (INICET NOV 2022)</span></p>",
      "unique_key": "Q6252267",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794193,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ileocolic, right colic and trunk of middle colic.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">During an extended right colectomy, the ileocolic, right colic, and trunk of the middle colic vessels are typically resected to prevent the spread of cancer in proximal transverse colon carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The stem of the middle colic and the left colic artery are not resected during an extended right colectomy as they are not directly involved with the blood supply to the proximal transverse colon. It is important to note that the surgical management of colon cancer depends on the stage and location of the tumor and may involve various surgical techniques, including colectomy and lymphadenectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Types of radical colectomies and vessels ligated:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Right hemicolectomy: Ileocolic, right colic and right branch of middle colic artery</span></li><li><span style=\"font-size:12.0pt;\">Extended right hemicolectomy: Ileocolic, right colic and stem/origin of middle colic artery</span></li><li><span style=\"font-size:12.0pt;\">Left hemicolectomy: Left colic and sigmoid artery</span></li></ol>",
      "correct_choice_id": 57551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6986,
      "choices": [
        {
          "id": 27912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B &amp; C</span></span></span></p>"
        },
        {
          "id": 27913,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B, C &amp; D</span></span></span></p>"
        },
        {
          "id": 27914,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A &amp; B</span></span></span></p>"
        },
        {
          "id": 27915,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C &amp; D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is correct about the drugs used in Gout? (</span></span></span>INICET Nov 2020)</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Aspirin is not used as it decreases the uric acid excretion</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Diclofenac is used as it concentrates in the joint</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Indomethacin is used as it acts by multiple pathways</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Aspirin is used as it is most powerful NSAID</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "unique_key": "Q2943328",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794206,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. A, B &amp; C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin is not used as it decreases the uric acid excretion</strong>: This statement remains correct. Aspirin at low doses can decrease uric acid excretion, potentially worsening gout. Therefore, it is generally not recommended in the management of gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diclofenac is used as it concentrates in the joint</strong>: Diclofenac is commonly used in the management of gout due to its anti-inflammatory properties. It gets concentrated in joints and its effect in reducing inflammation and pain in gout is beneficial.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Indomethacin is used as it acts by multiple pathways</strong>: Indomethacin is indeed used in the treatment of gout. It is an NSAID that works by inhibiting the production of prostaglandins. It has multiple pathways of action including inhibition of COX and decrease in rate of phagocytosis of urate crystals. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin is used as it is the most powerful NSAID</strong>: This statement is incorrect for reasons previously mentioned. Aspirin, particularly at low doses, is not recommended for gout due to its potential to increase serum uric acid levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The preferred treatment for an acute gout attack is an NSAID (nonsteroidal anti-inflammatory drug), such as indomethacin. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A typical first-line treatment for gout is indomethacin. Besides suppressing prostaglandin synthesis, indomethacin and other NSAIDs also reduce rate of crystal phagocytosis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Furthermore, intraarticular steroids like methylprednisolone or triamcinolone may be given.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin is not utilized because it promotes renal retention of uric acid.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 27912,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16057,
      "choices": [
        {
          "id": 64188,
          "text": "<p><span style=\"font-size:12.0pt;\">III</span></p>"
        },
        {
          "id": 64189,
          "text": "<p><span style=\"font-size:12.0pt;\">VII</span></p>"
        },
        {
          "id": 64190,
          "text": "<p><span style=\"font-size:12.0pt;\">IV</span></p>"
        },
        {
          "id": 64191,
          "text": "<p><span style=\"font-size:12.0pt;\">VI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the cranial nerve passing through the given structure: (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/ai-16.jpg\" alt=\"\" width=\"286\" height=\"333\"></span></p>",
      "unique_key": "Q9761305",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794120,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. IV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given image, the dorsal aspect of the brainstem is marked and the cranial nerve that is passing there is the trochlear nerve (CN IV).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Trochlear nerve</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong> : The trochlear nerve is the only cranial nerve that emerges from the dorsal (posterior) aspect of the brain. Specifically, it originates from the dorsal surface of the midbrain, below the inferior colliculus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit </strong>proceed to the superior orbital fissure to enter the orbit.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It is a motor nerve that innervates a single extraocular muscle, the superior oblique muscle. The primary action of the superior oblique muscle is to intort (rotate inward), depress, and abduct the eyeball.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Oculomotor Nerve (III):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The oculomotor nerve originates in the anterior aspect of the midbrain. Specifically, its fibers arise from the oculomotor nucleus, which is located in the superior colliculus of the midbrain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: After emerging from the midbrain, it exits the brainstem at the level of the interpeduncular fossa (the space between the cerebral peduncles).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It innervates most of the muscles controlling eye movements. It also contains parasympathetic fibers that are involved in pupil constriction and the lens's accommodation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Facial Nerve (VII):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The facial nerve arises from the pons. Specifically, its fibers come from the facial nerve nucleus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: It emerges from the brainstem at the cerebellopontine angle, between the pons and the medulla. It exits lateral to the abducens nerve and medial to the vestibulocochlear nerve (VIII).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: The facial nerve controls the muscles of facial expression. It also has taste fibers from the anterior two-thirds of the tongue and carries parasympathetic fibers to salivary and lacrimal glands.</span><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Abducens Nerve (VI):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The abducens nerve originates in the pons. Its fibers arise from the abducens nucleus, which is located in the dorsal pons near the floor of the fourth ventricle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: It emerges from the ventral surface of the brainstem at the junction between the pons and the medulla, in the groove between the pons and the pyramid of the medulla.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It innervates the lateral rectus muscle, which abducts the eye.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The trochlear nerve is the fourth cranial nerve that originates in the midbrain at the level of the inferior colliculus from the trochlear nuclei. It is the only cranial nerve that emerges from the brainstem's dorsal surface and has the longest intracranial course.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The main actions of superior oblique are:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Depression in adducted position- Patients with trochlear nerve palsy have difficulty in looking downwards when eyes are in the adducted position.</span></li><li><span style=\"font-size:12.0pt;\">Abduction</span></li><li><span style=\"font-size:12.0pt;\">Intorsion of the eyeball.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-194331.JPG\" alt=\"\" width=\"1000\" height=\"471\"></span></p>",
      "correct_choice_id": 64190,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6692,
      "choices": [
        {
          "id": 26737,
          "text": "<p><span style=\"font-size:12.0pt;\">Pick's disease</span></p>"
        },
        {
          "id": 26738,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinson's disease</span></p>"
        },
        {
          "id": 26739,
          "text": "<p><span style=\"font-size:12.0pt;\">Huntington's disease</span></p>"
        },
        {
          "id": 26740,
          "text": "<p><span style=\"font-size:12.0pt;\">Wilson's disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a type of subcortical dementia?(INICET NOV 2020)</span></p>",
      "unique_key": "Q5440010",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794130,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Pick's disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To approach this question, we need to differentiate between cortical and subcortical dementias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a type of frontotemporal dementia and is cortical. It primarily affects the frontal and temporal lobes. Memory may be preserved in the early stages, but personality and language changes are prominent. Therefore, it doesn't fall under the subcortical category, making it the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Parkinson's disease: </strong>Parkinson's primarily affects the basal ganglia in the brain, which is a subcortical structure. The primary symptoms are motoric (tremor, rigidity, bradykinesia), but dementia can develop in the later stages of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Huntington's disease: </strong>This is a genetic disorder that affects the basal ganglia, especially the caudate nucleus, which is also a subcortical structure. Cognitive decline and psychiatric symptoms are common.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Wilson's disease: </strong>This is a genetic disorder that leads to copper accumulation in the body, including the brain. The basal ganglia is one of the primary areas affected, making the dementia subcortical in nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the options, Pick's disease is the only cortical dementia, making it the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/12/screenshot-2023-10-12-124045.jpg\" alt=\"\" width=\"1000\" height=\"577\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: A Short Textbook of Psychiatry, 7th edition, Page No 24.</strong></span></p>",
      "correct_choice_id": 26737,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24767,
      "choices": [
        {
          "id": 99029,
          "text": "<p><span style=\"font-size:11.0pt;\">Torsade’s de pointes</span></p>"
        },
        {
          "id": 99030,
          "text": "<p><span style=\"font-size:11.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 99031,
          "text": "<p><span style=\"font-size:11.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 99032,
          "text": "<p><span style=\"font-size:11.0pt;\">Monomorphic ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the given ECG? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-133825.png\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
      "unique_key": "Q4433131",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794186,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Torsade’s de pointes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsade’s de pointes is characterized by a polymorphic ventricular tachycardia with varying QRS complex amplitudes and a twisting around the baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ventricular fibrillation:</strong> Characterized by a chaotic and irregular waveform without identifiable QRS complexes.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Atrial flutter</strong>: Shows a sawtooth pattern of atrial activity.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Monomorphic ventricular tachycardia:</strong> Shows uniform QRS complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsade’s de pointes are a type of polymorphic ventricular tachycardia with a characteristic twisting pattern.</span></p>",
      "correct_choice_id": 99029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7085,
      "choices": [
        {
          "id": 28308,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab</span></span></span></p>"
        },
        {
          "id": 28309,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab</span></span></span></p>"
        },
        {
          "id": 28310,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trastuzumab</span></span></span></p>"
        },
        {
          "id": 28311,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ipilimumab</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which among the following drugs is the new FDA approved immune check point inhibitor for carcinoma endometrium?</span></span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q1064135",
      "question_audio": null,
      "question_video": null,
      "map_id": 22794111,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Pembrolizumab</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The new FDA-approved immune checkpoint inhibitor for carcinoma endometrium is Pembrolizumab.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab is a monoclonal antibody against PD-1 receptor (Programmed Death Receptor) that can be used for many cancers including endometrial carcinoma. Some of the other cancers where it is useful are:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metastatic urothelial cancer</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Refractory melanoma</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&rsquo;s Lymphoma</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Merkel cell cancer</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemotherapy Refractory Head and Neck Cancer</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Nivolumab:</strong> is an immune checkpoint inhibitor that acts by inhibiting programmed death receptor - 1 (PD-1) and is used for the treatment of advanced melanoma and relapsed/refractory classical Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Trastuzumab: </strong>is a monoclonal antibody that inhibits the HER2 receptor. It is used in the treatment of HER2-positive breast cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Ipilimumab:</strong> is a monoclonal antibody that binds to cytotoxic T lymphocyte-associated Protein 4 (CTLA-4) and is approved for the treatment of late-stage melanoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab is the new FDA-approved immune checkpoint inhibitor for carcinoma endometrium. It works by blocking the PD-1 receptor, enhancing the immune system&#39;s ability to attack cancer cells. It is also used for treating several other cancers, including metastatic urothelial cancer, refractory melanoma, Hodgkin&rsquo;s lymphoma, Merkel cell cancer, and chemotherapy-refractory head and neck cancer.</span></span></span></p>",
      "correct_choice_id": 28309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}